Research across borders

Worldwide Study Finder

Where are peptides being studied? Explore registered human studies by product, phase, condition and location — from early development through Phase 4, alongside studies where phase does not apply.

Searchable results come from ClinicalTrials.gov and include international sites. For broader coverage, use the worldwide and regional registries below. No single registry captures every study.

Find studies Explore world registries Peptide directory

Find a study

Enter a peptide, product, condition or location. Try generic names, brand names and development codes separately. Results are registry search matches, not automatically verified links to a WPF peptide record.

Search terms are sent to ClinicalTrials.gov and appear in the page URL. Do not enter personal or medical identifying information. Registry records are served with up to a one-hour cache; registry updates themselves can lag real-world changes.

Registry search results

Matching records; showing 20 on this page, newest registry updates first. Search checked 2026-10-08 04:18 UTC. Counts are registry matches, not unique peptides or a worldwide total.

Phase not reported / not applicableCompletedOBSERVATIONAL

CHOICE: CHanges to Treatment and Outcomes in Patients With Type 2 Diabetes Initiating InjeCtablE Therapy

ClinicalTrials.gov · NCT00635492 · Registry updated: 2015-04-09

Condition / research focus: Type 2 Diabetes Mellitus
Sponsor: AstraZeneca
Countries with listed sites: Denmark · France · Germany · Greece · Sweden
Registry dates and results: Start: 2008-01. Completion: 2011-12 (may be estimated). Results are posted in this registry.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

exenatide (drug) — also listed as: Byetta
any human insulin or analog insulin(s) given in any regimen by subcutaneous injection (drug)

Where the study takes place — 96 listed sites

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

Research Site
Amager, Denmark
Site recruitment: Not reported
Research Site
Rønne, Denmark
Site recruitment: Not reported
Research Site
Toul, France
Site recruitment: Not reported
Research Site
Alsfeld, Germany
Site recruitment: Not reported
Research
Aschaffenburg, Germany
Site recruitment: Not reported
Research Site
Augsburg, Germany
Site recruitment: Not reported
Research Site
Aßlar, Germany
Site recruitment: Not reported
Research Site
Bad Aibling, Germany
Site recruitment: Not reported
Research Site
Bad Homburg, Germany
Site recruitment: Not reported
Research Site
Bad Mergentheim, Germany
Site recruitment: Not reported
Research Site
Bergheim, Germany
Site recruitment: Not reported
Research Site
Berlin, Germany
Site recruitment: Not reported
Research
Birkenfeld, Germany
Site recruitment: Not reported
Research Site
Bosenheim, Germany
Site recruitment: Not reported
Research Site
Bruchsal, Germany
Site recruitment: Not reported
Research Site
Dortmund, Germany
Site recruitment: Not reported
Research Site
Dresden, Germany
Site recruitment: Not reported
Research Site
Duisburg, Germany
Site recruitment: Not reported
Research Site
Eberswalde, Germany
Site recruitment: Not reported
Research Site
Eilenburg, Germany
Site recruitment: Not reported
Research Site
Eisenach, Germany
Site recruitment: Not reported
Research Site
Erfurt, Germany
Site recruitment: Not reported
Research Site
Essen, Germany
Site recruitment: Not reported
Research Site
Frankfurt, Germany
Site recruitment: Not reported
Research Site
Gebhardshain, Germany
Site recruitment: Not reported
Research Site
Gersfeld, Germany
Site recruitment: Not reported
Research Site
Giessen, Germany
Site recruitment: Not reported
Research Site
Gifhorn, Germany
Site recruitment: Not reported
Research Site
Grassau, Germany
Site recruitment: Not reported
Research Site
Groß-Gerau, Germany
Site recruitment: Not reported
Research Site
Hadmersleben, Germany
Site recruitment: Not reported
Research Site
Halle, Germany
Site recruitment: Not reported
Research Site
Hamburg, Germany
Site recruitment: Not reported
Research Site
Hammelburg, Germany
Site recruitment: Not reported
Research Site
Hennigsdorf, Germany
Site recruitment: Not reported
Research Site
Hohenmölsen, Germany
Site recruitment: Not reported
Research Site
Ismaning, Germany
Site recruitment: Not reported
Research Site
Köthen, Germany
Site recruitment: Not reported
Research Site
Kutenholz, Germany
Site recruitment: Not reported
Research Site
Langen, Germany
Site recruitment: Not reported
Research Site
Langenfeld, Germany
Site recruitment: Not reported
Research Site
Leipzig, Germany
Site recruitment: Not reported
Research Site
Lichtenfels, Germany
Site recruitment: Not reported
Research Site
Ludwigsburg, Germany
Site recruitment: Not reported
Research Site
Lüneburg, Germany
Site recruitment: Not reported
Research Site
Marburg, Germany
Site recruitment: Not reported
Research Site
Mayen, Germany
Site recruitment: Not reported
Research Site
Meissen, Germany
Site recruitment: Not reported
Research Site
Minden, Germany
Site recruitment: Not reported
Research Site
Mönchengladbach, Germany
Site recruitment: Not reported
Research Site
München, Germany
Site recruitment: Not reported
Research Site
Münster, Germany
Site recruitment: Not reported
Research Site
Nassau, Germany
Site recruitment: Not reported
Research Site
Netphen, Germany
Site recruitment: Not reported
Research Site
Oberhausen, Germany
Site recruitment: Not reported
Research Site
Pirmasens, Germany
Site recruitment: Not reported
Research Site
Recklinghausen, Germany
Site recruitment: Not reported
Research Site
Rehburg-Loccum, Germany
Site recruitment: Not reported
Research Site
Reichenbach, Germany
Site recruitment: Not reported
Research Site
Riesa, Germany
Site recruitment: Not reported
Research Site
Saarbrücken, Germany
Site recruitment: Not reported
Research Site
Saarlouis, Germany
Site recruitment: Not reported
Research Site
Schkeuditz, Germany
Site recruitment: Not reported
Research Site
Schönwalde, Germany
Site recruitment: Not reported
Research Site
Schweinfurt, Germany
Site recruitment: Not reported
Research Site
Seligenstadt, Germany
Site recruitment: Not reported
Research Site
Siegen, Germany
Site recruitment: Not reported
Research Site
Stockach, Germany
Site recruitment: Not reported
Research Site
Thale, Germany
Site recruitment: Not reported
Research Site
Ueckermünde, Germany
Site recruitment: Not reported
Research Site
Übach-Palenberg, Germany
Site recruitment: Not reported
Research Site
Villingen-Schwenningen, Germany
Site recruitment: Not reported
Research Site
Völklingen, Germany
Site recruitment: Not reported
Research Site
Warburg, Germany
Site recruitment: Not reported
Research Site
Weißenberg, Germany
Site recruitment: Not reported
Research Site
Werl, Germany
Site recruitment: Not reported
Research Site
Westfalica, Germany
Site recruitment: Not reported
Research Site
Wilhelmshaven, Germany
Site recruitment: Not reported
Research Site
Wurzen, Germany
Site recruitment: Not reported
Research Site
Kozani, Greece
Site recruitment: Not reported
Research Site
N. Efkarpia, Greece
Site recruitment: Not reported
Research Site
Thessaloniki, Greece
Site recruitment: Not reported
Research Site
Véroia, Greece
Site recruitment: Not reported
Research Site
Angered, Sweden
Site recruitment: Not reported
Research Site
Ängelholm, Sweden
Site recruitment: Not reported
Research Site
Dalby, Sweden
Site recruitment: Not reported
Research Site
Falun, Sweden
Site recruitment: Not reported
Research Site
Gothenburg, Sweden
Site recruitment: Not reported
Research Site
Limhamn, Sweden
Site recruitment: Not reported
Research Site
Luleå, Sweden
Site recruitment: Not reported
Research Site
Malmö, Sweden
Site recruitment: Not reported
Research Site
Skivarp, Sweden
Site recruitment: Not reported
Research Site
Skövde, Sweden
Site recruitment: Not reported
Research Site
Stockholm, Sweden
Site recruitment: Not reported
Research Site
Vadstena, Sweden
Site recruitment: Not reported
Research Site
Västervik, Sweden
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 4CompletedINTERVENTIONAL

Comparison of the Effect of Exenatide Versus Sitagliptin on 24-hour Average Glucose in Patients With Type 2 Diabetes on Metformin or a Thiazolidinedione

ClinicalTrials.gov · NCT00729326 · Registry updated: 2015-04-09

Condition / research focus: Type 2 Diabetes Mellitus
Sponsor: AstraZeneca
Countries with listed sites: United States
Registry dates and results: Start: 2008-08. Completion: 2009-10 (may be estimated). Results are posted in this registry.

Products and interventions (4)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

exenatide (drug) — also listed as: Byetta
sitagliptin (drug) — also listed as: Januvia
placebo (drug)
placebo (drug)

Where the study takes place — 1 listed sites

Research Site
San Antonio, Texas, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase not reported / not applicableCompletedOBSERVATIONAL

Exenatide and Basal Insulins Use in the Real Setting: an Observational Study in Patients With Type 2 Diabetes

ClinicalTrials.gov · NCT01060059 · Registry updated: 2015-04-09

Condition / research focus: Type 2 Diabetes Mellitus
Sponsor: AstraZeneca
Countries with listed sites: Italy
Registry dates and results: Start: 2010-04. Completion: 2012-05 (may be estimated). Results are posted in this registry.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

exenatide (drug) — also listed as: BYETTA
basal insulin (drug)

Where the study takes place — 50 listed sites

Research site
Acquaviva delle Fonti, Italy
Site recruitment: Not reported
Research site
Anzio, Italy
Site recruitment: Not reported
Research site
Bassano del Grappa, Italy
Site recruitment: Not reported
Research site
Bologna, Italy
Site recruitment: Not reported
Research site
Brindisi, Italy
Site recruitment: Not reported
Research site
Cagliari, Italy
Site recruitment: Not reported
Research site
Campi Salentina, Italy
Site recruitment: Not reported
Research site
Casarano, Italy
Site recruitment: Not reported
Research site
Caserta, Italy
Site recruitment: Not reported
Research site
Cesena, Italy
Site recruitment: Not reported
Research site
Chieri, Italy
Site recruitment: Not reported
Research site
Cisternino, Italy
Site recruitment: Not reported
Research site
Copertino, Italy
Site recruitment: Not reported
Research site
Cremona, Italy
Site recruitment: Not reported
Research site
Distretto Vittoria, Italy
Site recruitment: Not reported
Research site
Fermo, Italy
Site recruitment: Not reported
Research site
Ferrara, Italy
Site recruitment: Not reported
Research site
Fidenza, Italy
Site recruitment: Not reported
Research site
Florence, Italy
Site recruitment: Not reported
Research site
Forlì, Italy
Site recruitment: Not reported
Research site
Genova, Italy
Site recruitment: Not reported
Research site
Germaneto, Italy
Site recruitment: Not reported
Research site
Lecce, Italy
Site recruitment: Not reported
Research site
Livorno, Italy
Site recruitment: Not reported
Research site
Lucca, Italy
Site recruitment: Not reported
Research site
Manfredonia (Le), Italy
Site recruitment: Not reported
Research site
Mariano Comense, Italy
Site recruitment: Not reported
Research site
Messina, Italy
Site recruitment: Not reported
Research site
Milan, Italy
Site recruitment: Not reported
Research site
Monza, Italy
Site recruitment: Not reported
Research site
Naples, Italy
Site recruitment: Not reported
Research site
Novara, Italy
Site recruitment: Not reported
Research site
Olbia, Italy
Site recruitment: Not reported
Research site
Palermo, Italy
Site recruitment: Not reported
Research site
Palmi, Italy
Site recruitment: Not reported
Research site
Parma, Italy
Site recruitment: Not reported
Research site
Pavia, Italy
Site recruitment: Not reported
Research site
Pisa, Italy
Site recruitment: Not reported
Research site
Potenza, Italy
Site recruitment: Not reported
Research site
Rimini, Italy
Site recruitment: Not reported
Research site
Roma, Italy
Site recruitment: Not reported
Research site
Rossano Scalo, Italy
Site recruitment: Not reported
Research site
Salerno, Italy
Site recruitment: Not reported
Research site
San Giovanni Rotondo, Italy
Site recruitment: Not reported
Research site
Schio, Italy
Site recruitment: Not reported
Research site
Sesto San Giovanni, Italy
Site recruitment: Not reported
Research site
Siena, Italy
Site recruitment: Not reported
Research site
Treviso, Italy
Site recruitment: Not reported
Research site
Trieste, Italy
Site recruitment: Not reported
Research site
Varese, Italy
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 3CompletedINTERVENTIONAL

Safety and Efficacy of Exenatide Once Weekly Injection Versus Metformin, Dipeptidyl Peptidase-4 Inhibitor, or Thiazolidinedione as Monotherapy in Drug-Naive Patients With Type 2 Diabetes (DURATION-4)

ClinicalTrials.gov · NCT00676338 · Registry updated: 2015-04-09

Condition / research focus: Type 2 Diabetes Mellitus
Sponsor: AstraZeneca
Countries with listed sites: Argentina · Belgium · Brazil · Canada · France · Germany · Hungary · India · Israel · Italy · Mexico · Poland · Puerto Rico · Romania · Russia · Slovakia · South Africa · South Korea · Spain · Turkey (Türkiye) · United Kingdom · United States
Registry dates and results: Start: 2008-11. Completion: 2011-01 (may be estimated). Results are posted in this registry.

Products and interventions (4)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

exenatide once weekly (drug)
metformin (drug)
sitagliptin (drug)
pioglitazone (drug)

Where the study takes place — 106 listed sites

Research Site
Buena Park, California, United States
Site recruitment: Not reported
Research Site
Los Angeles, California, United States
Site recruitment: Not reported
Research Site
Valencia, California, United States
Site recruitment: Not reported
Research Site
Jacksonville, Florida, United States
Site recruitment: Not reported
Research Site
Atlanta, Georgia, United States
Site recruitment: Not reported
Research Site
Meridian, Idaho, United States
Site recruitment: Not reported
Research Site
Des Moines, Iowa, United States
Site recruitment: Not reported
Research Site
Grand Rapids, Michigan, United States
Site recruitment: Not reported
Research Site
Minneapolis, Minnesota, United States
Site recruitment: Not reported
Research Site
Billings, Montana, United States
Site recruitment: Not reported
Research Site
Toms River, New Jersey, United States
Site recruitment: Not reported
Research Site
Wilmington, North Carolina, United States
Site recruitment: Not reported
Research Site
Danville, Pennsylvania, United States
Site recruitment: Not reported
Research Site
Philadelphia, Pennsylvania, United States
Site recruitment: Not reported
Research Site
Wilke Barre, Pennsylvania, United States
Site recruitment: Not reported
Research Site
Austin, Texas, United States
Site recruitment: Not reported
Research Site
El Paso, Texas, United States
Site recruitment: Not reported
Research Site
New Branufels, Texas, United States
Site recruitment: Not reported
Research Site
Buenos Aires, Argentina
Site recruitment: Not reported
Research Site
Mar del Plata, Argentina
Site recruitment: Not reported
Research Site
Leuven, Belgium
Site recruitment: Not reported
Research Site
Marchovelette, Belgium
Site recruitment: Not reported
Research Site
Tessenderlo, Belgium
Site recruitment: Not reported
Research Site
Brasília, Brazil
Site recruitment: Not reported
Research Site
Campinas, Brazil
Site recruitment: Not reported
Research Site
Curitiba, Brazil
Site recruitment: Not reported
Research Site
Fortaleza, Brazil
Site recruitment: Not reported
Research Site
Joinville, Brazil
Site recruitment: Not reported
Research SIte
Porto Alegre, Brazil
Site recruitment: Not reported
Research Site
Recife, Brazil
Site recruitment: Not reported
Research Site
São Paulo, Brazil
Site recruitment: Not reported
Research Site
Coquitlam, British Columbia, Canada
Site recruitment: Not reported
Research Site
Penticton, British Columbia, Canada
Site recruitment: Not reported
Research Site
Ottawa, Ontario, Canada
Site recruitment: Not reported
Research Site
Gatineu, Quebec, Canada
Site recruitment: Not reported
Research Site
Mississauga, Canada
Site recruitment: Not reported
Research Site
Petitcodiac, Canada
Site recruitment: Not reported
Research Site
Pointe-Claire, Canada
Site recruitment: Not reported
Research Site
Regina, Canada
Site recruitment: Not reported
Research Site
Saint John, Canada
Site recruitment: Not reported
Research Site
Châteaugiron, France
Site recruitment: Not reported
Research Site
Mûrs-Erigné, France
Site recruitment: Not reported
Research Site
Nantes, France
Site recruitment: Not reported
Research Site
Vieux-Condé, France
Site recruitment: Not reported
Research Site
Dresden, Germany
Site recruitment: Not reported
Research Site
Mainz, Germany
Site recruitment: Not reported
Research Site
Münster, Germany
Site recruitment: Not reported
Research Site
Rodgau, Germany
Site recruitment: Not reported
Research Site
Budapest, Hungary
Site recruitment: Not reported
Research Site
Gyula, Hungary
Site recruitment: Not reported
Research Site
Hódmezővásárhely, Hungary
Site recruitment: Not reported
Research Site
Pécs, Hungary
Site recruitment: Not reported
Research Site
Ahmedabad, India
Site recruitment: Not reported
Research Site
Bangalore, India
Site recruitment: Not reported
Research Site
Channai, India
Site recruitment: Not reported
Research Site
Kochi, India
Site recruitment: Not reported
Research Site
Mumbai, India
Site recruitment: Not reported
Research Site
New Dehli, India
Site recruitment: Not reported
Research SIte
Pune, India
Site recruitment: Not reported
Research Site
Holon, Israel
Site recruitment: Not reported
Research SIte
Tel Litwinsky, Israel
Site recruitment: Not reported
Research Site
Florence, Italy
Site recruitment: Not reported
Research Site
Milan, Italy
Site recruitment: Not reported
Research Site
Siena, Italy
Site recruitment: Not reported
Research Site
Chihuahua City, Mexico
Site recruitment: Not reported
Research Site
Guadalajara, Mexico
Site recruitment: Not reported
Research Site
Monterrey, Mexico
Site recruitment: Not reported
Research Site
Lublin, Poland
Site recruitment: Not reported
Research Site
Szczecin, Poland
Site recruitment: Not reported
Research Site
Wroclaw, Poland
Site recruitment: Not reported
Research Site
Manati, Puerto Rico
Site recruitment: Not reported
Research Site
Toa Baja, Puerto Rico
Site recruitment: Not reported
Research Site
Galati, Romania
Site recruitment: Not reported
Research Site
Oradea, Romania
Site recruitment: Not reported
Research Site
Târgu Mureş, Romania
Site recruitment: Not reported
Research Site
Arkhangelsk, Russia
Site recruitment: Not reported
Research Site
Moscow, Russia
Site recruitment: Not reported
Research Site
Rostov-on-Don, Russia
Site recruitment: Not reported
Research Site
Saint Petersburg, Russia
Site recruitment: Not reported
Research Site
Stavropol, Russia
Site recruitment: Not reported
Research Site
Bratislava, Slovakia
Site recruitment: Not reported
Research Site
Trebišov, Slovakia
Site recruitment: Not reported
Research Site
Johannesburg, South Africa
Site recruitment: Not reported
Research Site
Kempton Park, South Africa
Site recruitment: Not reported
Research Site
Midrand, South Africa
Site recruitment: Not reported
Research Site
Soweto, South Africa
Site recruitment: Not reported
Research Site
Busan, South Korea
Site recruitment: Not reported
Research Site
Daegu, South Korea
Site recruitment: Not reported
Research Site
Jeonju, South Korea
Site recruitment: Not reported
Research Site
Seoul, South Korea
Site recruitment: Not reported
Research Site
Sungnam, South Korea
Site recruitment: Not reported
Research Site
Alicante, Spain
Site recruitment: Not reported
Research Site
Barcelona, Spain
Site recruitment: Not reported
Research Site
Madrid, Spain
Site recruitment: Not reported
Research Site
Seville, Spain
Site recruitment: Not reported
Research Site
Ankara, Turkey (Türkiye)
Site recruitment: Not reported
Research Site
Istanbul, Turkey (Türkiye)
Site recruitment: Not reported
Research Site
Sisli-Istanbul, Turkey (Türkiye)
Site recruitment: Not reported
Research Site
Bath, United Kingdom
Site recruitment: Not reported
Research Site
Birmingham, United Kingdom
Site recruitment: Not reported
Research Site
Edinburgh, United Kingdom
Site recruitment: Not reported
Research Site
Frome, United Kingdom
Site recruitment: Not reported
Research Site
Guildford, United Kingdom
Site recruitment: Not reported
Research Site
Hull, United Kingdom
Site recruitment: Not reported
Research Site
Sheffield, United Kingdom
Site recruitment: Not reported
Research Site
Swansea, United Kingdom
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 4CompletedINTERVENTIONAL

A Comparison of Adding Exenatide With Switching to Exenatide in Patients With Type 2 Diabetes Experiencing Inadequate Glycemic Control With Sitagliptin Plus Metformin

ClinicalTrials.gov · NCT00870194 · Registry updated: 2015-04-09

Condition / research focus: Type 2 Diabetes Mellitus
Sponsor: AstraZeneca
Countries with listed sites: Argentina · Australia · Germany · Greece · India · Mexico · South Korea
Registry dates and results: Start: 2009-03. Completion: 2010-04 (may be estimated). Results are posted in this registry.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

exenatide and sitagliptin (drug) — also listed as: exenatide-Byetta; sitagliptin-Januvia
exenatide and placebo (drug) — also listed as: exenatide-Byetta

Where the study takes place — 36 listed sites

Research Site
Buenos Aires, Argentina
Site recruitment: Not reported
Research Site
Morón, Argentina
Site recruitment: Not reported
Research Site
Adelaide, Australia
Site recruitment: Not reported
Research Site
Geelong, Australia
Site recruitment: Not reported
Research Site
Melbourne, Australia
Site recruitment: Not reported
Research Site
Aschaffenburg, Germany
Site recruitment: Not reported
Research Site
Aßlar, Germany
Site recruitment: Not reported
Research Site
Beckum-Neubeckum, Germany
Site recruitment: Not reported
Research Site
Berlin, Germany
Site recruitment: Not reported
Research Site
Bosenheim, Germany
Site recruitment: Not reported
Research Site
Essen, Germany
Site recruitment: Not reported
Research Site
Falkensee, Germany
Site recruitment: Not reported
Research Site
Furth im Wald, Germany
Site recruitment: Not reported
Research Site
Grevenbroich, Germany
Site recruitment: Not reported
Research Site
Hohenmölsen, Germany
Site recruitment: Not reported
Research Site
Leipzig, Germany
Site recruitment: Not reported
Research Site
Neuwied, Germany
Site recruitment: Not reported
Research Site
Othmarschen, Germany
Site recruitment: Not reported
Research Site
Pohlheim, Germany
Site recruitment: Not reported
Research Site
Speyer, Germany
Site recruitment: Not reported
Research Site
Athens, Greece
Site recruitment: Not reported
Research Site
Thessaloniki, Greece
Site recruitment: Not reported
Research Site
Ahmedabad, India
Site recruitment: Not reported
Research Site
Bangalore, India
Site recruitment: Not reported
Research Site
Coimbatore, India
Site recruitment: Not reported
Research Site
Indore, India
Site recruitment: Not reported
Research Site
Jaipur, India
Site recruitment: Not reported
Research Site
Coatzacoalcos, Mexico
Site recruitment: Not reported
Research Site
Guadalajara, Mexico
Site recruitment: Not reported
Research Site
Mérida, Mexico
Site recruitment: Not reported
Research Site
Monterrey, Mexico
Site recruitment: Not reported
Research Site
Tampico, Mexico
Site recruitment: Not reported
Research Site
Daegu, South Korea
Site recruitment: Not reported
Research Site
Gwangju, South Korea
Site recruitment: Not reported
Research Site
Seoul, South Korea
Site recruitment: Not reported
Research Site
Ulsan, South Korea
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 3CompletedINTERVENTIONAL

A Study to Examine the Effects of Exenatide Once-Weekly Injection on Glucose Control and Safety in Asian Subjects

ClinicalTrials.gov · NCT00917267 · Registry updated: 2015-04-09

Condition / research focus: Type 2 Diabetes Mellitus
Sponsor: AstraZeneca
Countries with listed sites: China · India · Japan · South Korea · Taiwan
Registry dates and results: Start: 2009-07. Completion: 2011-04 (may be estimated). Results are posted in this registry.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

exenatide once weekly (drug)
exenatide twice daily (drug) — also listed as: Byetta

Where the study takes place — 42 listed sites

Research Site
Beijing, China
Site recruitment: Not reported
Research Site
Chengdu, China
Site recruitment: Not reported
Research Site
Chongqin, China
Site recruitment: Not reported
Research Site
Guangzhou, China
Site recruitment: Not reported
Research Site
Shanghai, China
Site recruitment: Not reported
Research Site
Ahmedabad, India
Site recruitment: Not reported
Research Site
Aligarh, India
Site recruitment: Not reported
Research Site
Bangalore, India
Site recruitment: Not reported
Research Site
Ghaziabad, India
Site recruitment: Not reported
Research Site
Hyderabaad, India
Site recruitment: Not reported
Research Site
Indore, India
Site recruitment: Not reported
Research Site
Kolkata, India
Site recruitment: Not reported
Research Site
Mumbai, India
Site recruitment: Not reported
Research Site
Pune, India
Site recruitment: Not reported
Research Site
Trivandrum, India
Site recruitment: Not reported
Research Site
Uttar Pradesh, India
Site recruitment: Not reported
Research Site
Varanasi, India
Site recruitment: Not reported
Research Site
Ageo, Japan
Site recruitment: Not reported
Research Site
Chiyoda-ku, Japan
Site recruitment: Not reported
Research Site
Izumisano, Japan
Site recruitment: Not reported
Research Site
Kashiwara, Japan
Site recruitment: Not reported
Research Site
Kitaazumi-gun, Japan
Site recruitment: Not reported
Research Site
Kumamoto, Japan
Site recruitment: Not reported
Research Site
Kurume, Japan
Site recruitment: Not reported
Research Site
Matsumoto, Japan
Site recruitment: Not reported
Research Site
Matsuyama, Japan
Site recruitment: Not reported
Research Site
Miyazaki, Japan
Site recruitment: Not reported
Research Site
Osaka, Japan
Site recruitment: Not reported
Research Site
Ōita, Japan
Site recruitment: Not reported
Research Site
Ōta-ku, Japan
Site recruitment: Not reported
Research Site
Shinjuku-ku, Japan
Site recruitment: Not reported
Research Site
Takatsuki, Japan
Site recruitment: Not reported
Research Site
Yokohama, Japan
Site recruitment: Not reported
Research Site
Bucheon-si, South Korea
Site recruitment: Not reported
Research Site
Daegu, South Korea
Site recruitment: Not reported
Research Site
Seoul, South Korea
Site recruitment: Not reported
Research Site
Changhua, Taiwan
Site recruitment: Not reported
Research Site
Chiayi City, Taiwan
Site recruitment: Not reported
Research Site
Kaohsiung City, Taiwan
Site recruitment: Not reported
Research Site
Tainan, Taiwan
Site recruitment: Not reported
Research Site
Taipei, Taiwan
Site recruitment: Not reported
Research Site
Taoyuan, Taiwan
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 3CompletedINTERVENTIONAL

Efficacy and Safety of Exenatide in Japanese Patients With Type 2 Diabetes Who Are Treated With Oral Antidiabetic(s)

ClinicalTrials.gov · NCT00577824 · Registry updated: 2015-04-09

Condition / research focus: Type 2 Diabetes
Sponsor: AstraZeneca
Countries with listed sites: Japan
Registry dates and results: Start: 2008-01. Completion: 2008-11 (may be estimated). Results are posted in this registry.

Products and interventions (3)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

exenatide (drug) — also listed as: LY2148568, Byetta
exenatide (drug) — also listed as: LY2148568, Byetta
placebo (drug)

Where the study takes place — 12 listed sites

Research Site
Chiba, Japan
Site recruitment: Not reported
Research Site
Fukuoka, Japan
Site recruitment: Not reported
Research Site
Fukushima, Japan
Site recruitment: Not reported
Research Site
Hyōgo, Japan
Site recruitment: Not reported
Research Site
Ibaraki, Japan
Site recruitment: Not reported
Research Site
Kanagawa, Japan
Site recruitment: Not reported
Research Site
Kumamoto, Japan
Site recruitment: Not reported
Research Site
Kyoto, Japan
Site recruitment: Not reported
Research Site
Nagano, Japan
Site recruitment: Not reported
Research Site
Osaka, Japan
Site recruitment: Not reported
Research Site
Ōita, Japan
Site recruitment: Not reported
Research Site
Tokyo, Japan
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 2CompletedINTERVENTIONAL

A Pilot Study of Effects of Exenatide on Body Weight in Non-Diabetic, Obese Patients

ClinicalTrials.gov · NCT00500370 · Registry updated: 2015-04-07

Condition / research focus: Obesity
Sponsor: AstraZeneca
Countries with listed sites: Puerto Rico · United States
Registry dates and results: Start: 2007-06. Completion: 2008-02 (may be estimated). Results are posted in this registry.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

exenatide (drug) — also listed as: Byetta
placebo (drug)

Where the study takes place — 16 listed sites

Research Site
Peoria, Arizona, United States
Site recruitment: Not reported
Research Site
Tucson, Arizona, United States
Site recruitment: Not reported
Research Site
Santa Ana, California, United States
Site recruitment: Not reported
Research Site
Indianapolis, Indiana, United States
Site recruitment: Not reported
Research Site
Topeka, Kansas, United States
Site recruitment: Not reported
Research Site
Wichita, Kansas, United States
Site recruitment: Not reported
Research Site
Baton Rouge, Louisiana, United States
Site recruitment: Not reported
Research Site
St Louis, Missouri, United States
Site recruitment: Not reported
Research Site
Oklahoma City, Oklahoma, United States
Site recruitment: Not reported
Research Site
Goose Creek, South Carolina, United States
Site recruitment: Not reported
Research Site
Spartanburg, South Carolina, United States
Site recruitment: Not reported
Research Site
Dallas, Texas, United States
Site recruitment: Not reported
Research Site
San Antonio, Texas, United States
Site recruitment: Not reported
Research Site
Renton, Washington, United States
Site recruitment: Not reported
Research Site
Ponce, Puerto Rico
Site recruitment: Not reported
Research Site
San Juan, Puerto Rico
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 3CompletedINTERVENTIONAL

Effects of Exenatide and Insulin Glargine in Subjects With Type 2 Diabetes

ClinicalTrials.gov · NCT00097500 · Registry updated: 2015-04-07

Condition / research focus: Type 2 Diabetes Mellitus
Sponsor: AstraZeneca
Countries with listed sites: Finland · Netherlands · Sweden
Registry dates and results: Start: 2004-09. Completion: 2009-12 (may be estimated). Results are posted in this registry.

Products and interventions (3)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

exenatide (drug) — also listed as: Byetta
Insulin glargine (drug) — also listed as: Lantus
Metformin (drug)

Where the study takes place — 3 listed sites

Research Site
Helsinki, Finland
Site recruitment: Not reported
Research Site
Amsterdam, Netherlands
Site recruitment: Not reported
Research Site
Gothenburg, Sweden
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 3CompletedINTERVENTIONAL

Safety and Efficacy of Exenatide in Patients With Type 2 Diabetes Using a Thiazolidinedione or a Thiazolidinedione and Metformin

ClinicalTrials.gov · NCT00603239 · Registry updated: 2015-04-07

Condition / research focus: Type 2 Diabetes Mellitus
Sponsor: AstraZeneca
Countries with listed sites: Canada · Mexico · Romania · South Africa · United States
Registry dates and results: Start: 2008-01. Completion: 2009-07 (may be estimated). Results are posted in this registry.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

exenatide (drug) — also listed as: Byetta
placebo (drug)

Where the study takes place — 25 listed sites

Research Site
Birmingham, Alabama, United States
Site recruitment: Not reported
Research Site
Concord, California, United States
Site recruitment: Not reported
Research Site
Fresno, California, United States
Site recruitment: Not reported
Research Site
Denver, Colorado, United States
Site recruitment: Not reported
Research Site
Las Vegas, Nevada, United States
Site recruitment: Not reported
Research Site
Mogadore, Ohio, United States
Site recruitment: Not reported
Research Site
Corvallis, Oregon, United States
Site recruitment: Not reported
Research Site
New Westminster, British Columbia, Canada
Site recruitment: Not reported
Research Site
Winnipeg, Manitoba, Canada
Site recruitment: Not reported
Research Site
Ajax, Ontario, Canada
Site recruitment: Not reported
Research Site
Cambridge, Ontario, Canada
Site recruitment: Not reported
Research Site
Windsor, Ontario, Canada
Site recruitment: Not reported
Research Site
Chihuahua City, Chihuahua, Mexico
Site recruitment: Not reported
Research Site
Celaya, Guanajuato, Mexico
Site recruitment: Not reported
Research Site
Mexico City, Mexico City, Mexico
Site recruitment: Not reported
Research Site
Monterrey, Nuevo León, Mexico
Site recruitment: Not reported
Research Site
Mexico City, Mexico
Site recruitment: Not reported
Research Site
Baia Mare, Romania
Site recruitment: Not reported
Research Site
Brasov, Romania
Site recruitment: Not reported
Research Site
Bucharest, Romania
Site recruitment: Not reported
Research Site
Dolj, Romania
Site recruitment: Not reported
Research Site
Iași, Romania
Site recruitment: Not reported
Research Site
Suceava, Romania
Site recruitment: Not reported
Research Site
Johannesburg, South Africa
Site recruitment: Not reported
Research Site
Pretoria, South Africa
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 3CompletedINTERVENTIONAL

An Exploratory Study of the Effect of Treatment Interruption on Safety of Exenatide in Patients With Type 2 Diabetes

ClinicalTrials.gov · NCT00516048 · Registry updated: 2015-04-07

Condition / research focus: Type 2 Diabetes Mellitus
Sponsor: AstraZeneca
Countries with listed sites: Australia · Canada · Hungary · Italy · South Korea
Registry dates and results: Start: 2007-08. Completion: 2008-04 (may be estimated). Results are posted in this registry.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

exenatide (drug) — also listed as: Byetta, AC2993, LY2148568

Where the study takes place — 13 listed sites

Research Site
Keswick, South Australia, Australia
Site recruitment: Not reported
Research Site
Calgary, Alberta, Canada
Site recruitment: Not reported
Research Site
Vancouver, British Columbia, Canada
Site recruitment: Not reported
Research Site
London, Ontario, Canada
Site recruitment: Not reported
Research Site
Budapest, Hungary
Site recruitment: Not reported
Research Site
Gyula, Hungary
Site recruitment: Not reported
Research Site
Zalaegerszeg, Hungary
Site recruitment: Not reported
Research Site
Milan, Italy
Site recruitment: Not reported
Research Site
Perugia, Italy
Site recruitment: Not reported
Research Site
Rome, Italy
Site recruitment: Not reported
Research Site
Seonnam City, South Korea
Site recruitment: Not reported
Research Site
Seoul, South Korea
Site recruitment: Not reported
Research Site
Suwon, South Korea
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 3CompletedINTERVENTIONAL

Effect of AC2993 Compared With Insulin Glargine in Patients With Type 2 Diabetes Also Using Combination Therapy With Sulfonylurea and Metformin

ClinicalTrials.gov · NCT00082381 · Registry updated: 2015-04-07

Condition / research focus: Diabetes Mellitus, Type 2
Sponsor: AstraZeneca
Countries with listed sites: Australia · Belgium · Brazil · Finland · Germany · Netherlands · Norway · Poland · Portugal · Puerto Rico · Spain · Sweden · United States
Registry dates and results: Start: 2003-06. Completion: 2008-07 (may be estimated). Results are posted in this registry.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Exenatide (AC2993) (drug) — also listed as: Byetta
Insulin glargine (drug) — also listed as: Lantus

Where the study takes place — 91 listed sites

Radiant Research-San Diego
San Diego, California, United States
Site recruitment: Not reported
Dorothy L. and James E. Frank Diabetes Research Institute
San Mateo, California, United States
Site recruitment: Not reported
Internal Medicine Associates Department of Research
Fort Myers, Florida, United States
Site recruitment: Not reported
Jacksonville Center for Clinical Research
Jacksonville, Florida, United States
Site recruitment: Not reported
Baptist Diabetes Associates
Miami, Florida, United States
Site recruitment: Not reported
Metabolic Research Institute, Inc.
West Palm Beach, Florida, United States
Site recruitment: Not reported
Springfield Diabetes & Endocrine Center
Springfield, Illinois, United States
Site recruitment: Not reported
Frederick Primary Care Associates
Frederick, Maryland, United States
Site recruitment: Not reported
Radiant Research, Inc.
St Louis, Missouri, United States
Site recruitment: Not reported
Lovelace Scientific Resources, Inc.
Las Vegas, Nevada, United States
Site recruitment: Not reported
Diabetes, Endocrine & Nutrition
Hampton, New Hampshire, United States
Site recruitment: Not reported
Lovelace Scientific Resources
Albuquerque, New Mexico, United States
Site recruitment: Not reported
Great Lakes Medical Research
Westfield, New York, United States
Site recruitment: Not reported
DOCS, Beth Israel Medical Center
Yonkers, New York, United States
Site recruitment: Not reported
Piedmont Medical Research Associates
Winston-Salem, North Carolina, United States
Site recruitment: Not reported
Jon Shapiro, MD
Philadelphia, Pennsylvania, United States
Site recruitment: Not reported
Endocrinology Consultants of East Tennessee
Knoxville, Tennessee, United States
Site recruitment: Not reported
Israel Hartman, MD
Arlington, Texas, United States
Site recruitment: Not reported
Diabetes & Glandular Research Associates, P.A.
San Antonio, Texas, United States
Site recruitment: Not reported
Jack Wahlen, MD
Ogden, Utah, United States
Site recruitment: Not reported
Rainier Clinical Research Center, Inc.
Renton, Washington, United States
Site recruitment: Not reported
Australian Clinical Research Centre
Miranda, New South Wales, Australia
Site recruitment: Not reported
Royal North Shore Hospital
St Leonards, New South Wales, Australia
Site recruitment: Not reported
Clinical Trial and Research Unit
Wollongong, New South Wales, Australia
Site recruitment: Not reported
Royal Brisbane Hospital
Brisbane, Queensland, Australia
Site recruitment: Not reported
Royal Adelaid Hospital
Adelaid, South Australia, Australia
Site recruitment: Not reported
Repatriation General Hospital
Daw Park, South Australia, Australia
Site recruitment: Not reported
SA Endocrine Clinical Research
Keswick, South Australia, Australia
Site recruitment: Not reported
Eastern Health (Box Hill Hospital)
Box Hill, Victoria, Australia
Site recruitment: Not reported
Royal Melbourne Hospital
Parkville, Victoria, Australia
Site recruitment: Not reported
Freemantle Hospital
Freemantle, Western Australia, Australia
Site recruitment: Not reported
UZ Antwerpen
Endegem, Belgium
Site recruitment: Not reported
UZ Gent
Ghent, Belgium
Site recruitment: Not reported
UZ Gasthuisberg
Leuven, Belgium
Site recruitment: Not reported
CHU Sart Tilman
Liège, Belgium
Site recruitment: Not reported
A.Z. Jan Palfijn
Merksem, Belgium
Site recruitment: Not reported
Sint Niklaasstraat
Sint-Gillis-Waas, Belgium
Site recruitment: Not reported
Hospital Nossa Senhora das Gracas
Curitiba, Brazil
Site recruitment: Not reported
Centro Integrado de Diabetes e Hipertensao
Fortaleza, Brazil
Site recruitment: Not reported
Centro de Pesquisas em Diabetes e Doencas Endocrino Metabolicas/HUWC/UFC
Fortaleza, Brazil
Site recruitment: Not reported
Santa Casa de Misericordia de Porto Alegre
Porto Alegre, Brazil
Site recruitment: Not reported
Eiran Sairaala c/o9 Clires
Helsinki, Finland
Site recruitment: Not reported
Torikeskuksen Laakariasema, Yliopistonkatu
Jyväskylä, Finland
Site recruitment: Not reported
Oulu Deakoness Institution
Oulu, Finland
Site recruitment: Not reported
Diabetologische Schwerpunktpraxis
Aschaffenburg, Germany
Site recruitment: Not reported
Diabetologische Scherpunktpraxis
Bosenheim, Germany
Site recruitment: Not reported
Diabetologische Schwerpunktpraxis
Dortmund, Germany
Site recruitment: Not reported
Krankenhaus Bethanien
Hamburg, Germany
Site recruitment: Not reported
Universitatskliniken des Saarlandes
Homburg/Saar, Germany
Site recruitment: Not reported
IKFE GmbH
Mainz, Germany
Site recruitment: Not reported
Profil Institut fur Stoffwechselforschung GmbH
Neuss, Germany
Site recruitment: Not reported
Diabetologische Schwerpunktpraxis
Neuwied, Germany
Site recruitment: Not reported
Diabetes Centrum Bilthoven
Bilthoven, Netherlands
Site recruitment: Not reported
Atrium Medisch Centrum Brunssum
Brunssum, Netherlands
Site recruitment: Not reported
Sint Antonius Ziekenhuis Nieuwegein
Nieuwegein, Netherlands
Site recruitment: Not reported
Refaja ziekenhuis
Stadskanaal, Netherlands
Site recruitment: Not reported
Medisch Centrum
Westeinde, Netherlands
Site recruitment: Not reported
Markeveien Spesialistpraksis
Bergen, Norway
Site recruitment: Not reported
Spesiallegetjenesten AS
Jessheim, Norway
Site recruitment: Not reported
Betanien Spesialistsenter
Oslo, Norway
Site recruitment: Not reported
Sykehuset Asker of Baerum HF
Rud, Norway
Site recruitment: Not reported
Forskningsstiftelsen Hjertelaget
Stravanger, Norway
Site recruitment: Not reported
Bydgoskie Centrum Diabetologii i Endokrynologii
Bydgoszcz, Poland
Site recruitment: Not reported
Oddzial Chorob Wewnetrznych
Częstochowa, Poland
Site recruitment: Not reported
NZOZ "Diab-Endo-Met"
Krakow, Poland
Site recruitment: Not reported
Poradnia Diabetologiczna
Lodz, Poland
Site recruitment: Not reported
Poradnia Diabetologiczna
Lublin, Poland
Site recruitment: Not reported
Oddzial Chorob Wewnetrznych
Mielec, Poland
Site recruitment: Not reported
Oddzial Chorob Wewnetrznych i Diabetologii
Warsaw, Poland
Site recruitment: Not reported
Wojewodzka Poradnia dla Chorych na Cukrzyce
Warsaw, Poland
Site recruitment: Not reported
Hospital Garcia de Orta-Servico de Endocrinologia
Almada, Portugal
Site recruitment: Not reported
Centro Hospitalar de Coimbra
Coimbra, Portugal
Site recruitment: Not reported
Associacao Protectora dos Diabeticos de Portugal
Lisbon, Portugal
Site recruitment: Not reported
Hospital Geral de Santo Antonio
Porto, Portugal
Site recruitment: Not reported
Universidad Central del Caribe
Bayamón, Puerto Rico
Site recruitment: Not reported
Hospital Alejandro Otero Lopez
Manati, Puerto Rico
Site recruitment: Not reported
Dr. Luis Ruiz
Ponce, Puerto Rico
Site recruitment: Not reported
RCMI-Clinical Research Center
Rio Piedras, Puerto Rico
Site recruitment: Not reported
San Juan Health Center
San Juan, Puerto Rico
Site recruitment: Not reported
Centro de Endocrinologia del Este
Yabucoa, Puerto Rico
Site recruitment: Not reported
Hospital Vega Baja
Alicante, Spain
Site recruitment: Not reported
Hospital Doce de Octubre
Madrid, Spain
Site recruitment: Not reported
Hospital Gral de Mostoles
Madrid, Spain
Site recruitment: Not reported
Hospital Virgen de Valme
Seville, Spain
Site recruitment: Not reported
Hospital la Ribera, Alzira
Valencia, Spain
Site recruitment: Not reported
Lundberglaboratoriet for diabetesforskning
Gothenburg, Sweden
Site recruitment: Not reported
Medicinska kliniken
Helsingborg, Sweden
Site recruitment: Not reported
Kliniska Forskningsenheren
Lund, Sweden
Site recruitment: Not reported
Diabetesmottagningen, Intermedicinska kliniken
Stockholm, Sweden
Site recruitment: Not reported
CME, M71
Stockholm, Sweden
Site recruitment: Not reported
Enheten for metabol kontroll
Stockholm, Sweden
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 3CompletedINTERVENTIONAL

A Trial Comparing Two Therapies: Basal Insulin/Glargine, Exenatide and Metformin Therapy (BET) or Basal Insulin/Glargine, Bolus Insulin Lispro and Metformin Therapy (BBT) in Subjects With Type 2 Diabetes

ClinicalTrials.gov · NCT00960661 · Registry updated: 2015-04-07

Condition / research focus: Type 2 Diabetes Mellitus
Sponsor: AstraZeneca
Countries with listed sites: Argentina · Belgium · Estonia · Finland · France · Germany · Greece · Italy · Mexico · Netherlands · Portugal · Puerto Rico · Romania · Russia · South Korea · Spain · Sweden · United Kingdom
Registry dates and results: Start: 2009-09. Completion: 2012-08 (may be estimated). Results are posted in this registry.

Products and interventions (4)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

exenatide (drug) — also listed as: Byetta
insulin lispro (drug) — also listed as: Humalog
Metformin (drug)
Insulin/ Glargine (drug)

Where the study takes place — 95 listed sites

Research Site
Buenos Aires, Argentina
Site recruitment: Not reported
Research Site
Caba, Argentina
Site recruitment: Not reported
Research Site
Capital Federal, Argentina
Site recruitment: Not reported
Research Site
Ciudad Autonoma de Buenos Aire, Argentina
Site recruitment: Not reported
Research Site
Ciudad de Buenos Aires, Argentina
Site recruitment: Not reported
Research Site
Corrientes, Argentina
Site recruitment: Not reported
Research Site
Rosario, Argentina
Site recruitment: Not reported
Research Site
San Rafael, Argentina
Site recruitment: Not reported
Research Site
Arlon, Belgium
Site recruitment: Not reported
Research Site
Bonheiden, Belgium
Site recruitment: Not reported
Research Site
Edegem, Belgium
Site recruitment: Not reported
Research Site
Merksem, Belgium
Site recruitment: Not reported
Research Site
Tallinn, Estonia
Site recruitment: Not reported
Research Site
Tartu, Estonia
Site recruitment: Not reported
Research Site
Helsinki, Finland
Site recruitment: Not reported
Research Site
Oulu, Finland
Site recruitment: Not reported
Research Site
Vantaa, Finland
Site recruitment: Not reported
Research Site
Angers, France
Site recruitment: Not reported
Research Site
Auxerre, France
Site recruitment: Not reported
Research Site
Bar-le-Duc, France
Site recruitment: Not reported
Research Site
Douai, France
Site recruitment: Not reported
Research Site
La Roche-sur-Yon, France
Site recruitment: Not reported
Research Site
La Rochelle, France
Site recruitment: Not reported
Research Site
Le Creuzot, France
Site recruitment: Not reported
Research Site
Lille, France
Site recruitment: Not reported
Research Site
Marseille, France
Site recruitment: Not reported
Research Site
Montpellier, France
Site recruitment: Not reported
Research Site
Nanterre, France
Site recruitment: Not reported
Research Site
Pessac, France
Site recruitment: Not reported
Research Site
Rennes, France
Site recruitment: Not reported
Research Site
Strasbourg, France
Site recruitment: Not reported
Research Site
Toulouse, France
Site recruitment: Not reported
Research Site
Vénissieux, France
Site recruitment: Not reported
Research Site
Bad Lauterberg im Harz, Germany
Site recruitment: Not reported
Research Site
Dippoldiswalde, Germany
Site recruitment: Not reported
Research Site
Friedrichsthal, Germany
Site recruitment: Not reported
Research Site
Goch, Germany
Site recruitment: Not reported
Research Site
Grevenbroich, Germany
Site recruitment: Not reported
Research Site
Hamburg, Germany
Site recruitment: Not reported
Research Site
Mainz, Germany
Site recruitment: Not reported
Research Site
Saarbrücken, Germany
Site recruitment: Not reported
Research Site
Athens, Greece
Site recruitment: Not reported
Research Site
Thessaloniki, Greece
Site recruitment: Not reported
Research Site
Florence, Italy
Site recruitment: Not reported
Research Site
Naples, Italy
Site recruitment: Not reported
Research Site
Olbia, Italy
Site recruitment: Not reported
Research Site
Perugia, Italy
Site recruitment: Not reported
Research Site
Trieste, Italy
Site recruitment: Not reported
Research Site
Verona, Italy
Site recruitment: Not reported
Research Site
Aguascalientes, Mexico
Site recruitment: Not reported
Research Site
Cuernavaca, Mexico
Site recruitment: Not reported
Research Site
Mexico City, Mexico
Site recruitment: Not reported
Research Site
Monterrey, Mexico
Site recruitment: Not reported
Research Site
Almere Stad, Netherlands
Site recruitment: Not reported
Research Site
Amsterdam, Netherlands
Site recruitment: Not reported
Research Site
Beek, Netherlands
Site recruitment: Not reported
Research Site
Groningen, Netherlands
Site recruitment: Not reported
Research Site
Heerlen, Netherlands
Site recruitment: Not reported
Research Site
Hoogeveen, Netherlands
Site recruitment: Not reported
Research Site
Sittard-Geleen, Netherlands
Site recruitment: Not reported
Research Site
The Hague, Netherlands
Site recruitment: Not reported
Research Site
Coimbra, Portugal
Site recruitment: Not reported
Research Site
Lisbon, Portugal
Site recruitment: Not reported
Research Site
Portugal, Portugal
Site recruitment: Not reported
Research Site
Hato Rey, Puerto Rico
Site recruitment: Not reported
Research Site
Bucharest, Romania
Site recruitment: Not reported
Research Site
Cluj-Napoca, Romania
Site recruitment: Not reported
Research Site
Constanța, Romania
Site recruitment: Not reported
Research Site
Craiova, Romania
Site recruitment: Not reported
Research Site
Oradea, Romania
Site recruitment: Not reported
Research Site
Ploieşti, Romania
Site recruitment: Not reported
Research Site
Arkhangelsk, Russia
Site recruitment: Not reported
Research Site
Rostov-on-Don, Russia
Site recruitment: Not reported
Research Site
Saint Petersburg, Russia
Site recruitment: Not reported
Research Site
Seoul, South Korea
Site recruitment: Not reported
Research Site
Ulsan, South Korea
Site recruitment: Not reported
Research Site
Wŏnju, South Korea
Site recruitment: Not reported
Research Site
A Coruña, Spain
Site recruitment: Not reported
Research Site
Alicante, Spain
Site recruitment: Not reported
Research Site
Barcelona, Spain
Site recruitment: Not reported
Research Site
Dos Hermanas, Spain
Site recruitment: Not reported
Research Site
Santander, Spain
Site recruitment: Not reported
Research Site
Valencia, Spain
Site recruitment: Not reported
Research Site
Halmstad, Sweden
Site recruitment: Not reported
Research Site
Karlstad, Sweden
Site recruitment: Not reported
Research Site
Lund, Sweden
Site recruitment: Not reported
Research Site
Malmö, Sweden
Site recruitment: Not reported
Research Site
Solna, Sweden
Site recruitment: Not reported
Research Site
Stockholm, Sweden
Site recruitment: Not reported
Research Site
Umeå, Sweden
Site recruitment: Not reported
Research Site
Bournemouth, United Kingdom
Site recruitment: Not reported
Research Site
Ipswich, United Kingdom
Site recruitment: Not reported
Research Site
Leicester, United Kingdom
Site recruitment: Not reported
Research Site
Penarth, United Kingdom
Site recruitment: Not reported
Research Site
Wakefield, United Kingdom
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 3CompletedINTERVENTIONAL

Effect of Exenatide Plus Metformin vs. Insulin Aspart Plus Metformin on Glycemic Control and Hypoglycemia in Patients With Type 2 Diabetes

ClinicalTrials.gov · NCT00434954 · Registry updated: 2015-04-07

Condition / research focus: Type 2 Diabetes Mellitus
Sponsor: AstraZeneca
Countries with listed sites: Germany
Registry dates and results: Start: 2007-02. Completion: 2009-06 (may be estimated). Results are posted in this registry.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

exenatide twice daily (BID) (drug) — also listed as: Byetta
premixed insulin aspart twice daily (BID) (drug)

Where the study takes place — 39 listed sites

Research Site
Bad Mergentheim, Germany
Site recruitment: Not reported
Research Site
Berlin, Germany
Site recruitment: Not reported
Research Site
Bosenheim, Germany
Site recruitment: Not reported
Research Site
Burghausen, Germany
Site recruitment: Not reported
Research Site
Datteln, Germany
Site recruitment: Not reported
Research Site
Dresden, Germany
Site recruitment: Not reported
Research Site
Essen, Germany
Site recruitment: Not reported
Research Site
Friedrichsthal, Germany
Site recruitment: Not reported
Research Site
Hildesheim, Germany
Site recruitment: Not reported
Research Site
Hirschhorn, Germany
Site recruitment: Not reported
Research Site
Hohenmölsen, Germany
Site recruitment: Not reported
Research Site
Jena, Germany
Site recruitment: Not reported
Research Site
Lehrte, Germany
Site recruitment: Not reported
Research Site
Leipzig, Germany
Site recruitment: Not reported
Research Site
Ludwigsburg, Germany
Site recruitment: Not reported
Research Site
Mannheim, Germany
Site recruitment: Not reported
Research Site
Marburg, Germany
Site recruitment: Not reported
Research Site
Marktheidenfeld, Germany
Site recruitment: Not reported
Research Site
Meissen, Germany
Site recruitment: Not reported
Research Site
München, Germany
Site recruitment: Not reported
Research Site
Offenbach, Germany
Site recruitment: Not reported
Research Site
Oschatz, Germany
Site recruitment: Not reported
Research Site
Pohlheim, Germany
Site recruitment: Not reported
Research Site
Regensburg, Germany
Site recruitment: Not reported
Research Site
Riesa, Germany
Site recruitment: Not reported
Research Site
Rodgau, Germany
Site recruitment: Not reported
Research Site
Roding, Germany
Site recruitment: Not reported
Research Site
Rosenheim, Germany
Site recruitment: Not reported
Research Site
Schlüchtern, Germany
Site recruitment: Not reported
Research Site
Schwedt, Germany
Site recruitment: Not reported
Research Site
Sinsheim, Germany
Site recruitment: Not reported
Research Site
Speyer, Germany
Site recruitment: Not reported
Research Site
Unterhaching, Germany
Site recruitment: Not reported
Research Site
Völklingen, Germany
Site recruitment: Not reported
Research Site
Wallerfing, Germany
Site recruitment: Not reported
Research Site
Wangen, Germany
Site recruitment: Not reported
Research Site
Warburg, Germany
Site recruitment: Not reported
Research Site
Wiesbaden, Germany
Site recruitment: Not reported
Research Site
Wolfsburg, Germany
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 3CompletedINTERVENTIONAL

Effect on Weight Loss of Exenatide Versus Placebo

ClinicalTrials.gov · NCT00375492 · Registry updated: 2015-04-07

Condition / research focus: Type 2 Diabetes Mellitus
Sponsor: AstraZeneca
Countries with listed sites: United States
Registry dates and results: Start: 2006-09. Completion: 2008-02 (may be estimated). Results are posted in this registry.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

exenatide (drug) — also listed as: Byetta
placebo (drug)

Where the study takes place — 10 listed sites

Research Site
Peoria, Arizona, United States
Site recruitment: Not reported
Research Site
Jacksonville, Florida, United States
Site recruitment: Not reported
Research Site
Orlando, Florida, United States
Site recruitment: Not reported
Research Site
Indianapolis, Indiana, United States
Site recruitment: Not reported
Research Site
Boston, Massachusetts, United States
Site recruitment: Not reported
Research Site
Minneapolis, Minnesota, United States
Site recruitment: Not reported
Research Site
St Louis, Missouri, United States
Site recruitment: Not reported
Research Site
Spartanburg, South Carolina, United States
Site recruitment: Not reported
Research Site
San Antonio, Texas, United States
Site recruitment: Not reported
Research Site
Renton, Washington, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 3CompletedINTERVENTIONAL

A Study to Compare the Glycemic Effects, Safety, and Tolerability of Exenatide Once Weekly to Those of Sitagliptin and Pioglitazone,in Subjects With Type 2 Diabetes Treated With Metformin (DURATION - 2)

ClinicalTrials.gov · NCT00637273 · Registry updated: 2015-04-07

Condition / research focus: Type 2 Diabetes Mellitus
Sponsor: AstraZeneca
Countries with listed sites: India · Mexico · United States
Registry dates and results: Start: 2008-01. Completion: 2009-07 (may be estimated). Results are posted in this registry.

Products and interventions (5)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

exenatide once weekly (drug)
sitagliptin (drug) — also listed as: Januvia
pioglitazone (drug)
placebo tablet (drug)
placebo once weekly (drug)

Where the study takes place — 62 listed sites

Research Site
Peoria, Arizona, United States
Site recruitment: Not reported
Research Site
Artesia, California, United States
Site recruitment: Not reported
Research Site
Concord, California, United States
Site recruitment: Not reported
Research Site
Encino, California, United States
Site recruitment: Not reported
Research Site
Greenbrae, California, United States
Site recruitment: Not reported
Research Site
La Mesa, California, United States
Site recruitment: Not reported
Research Site
Orange, California, United States
Site recruitment: Not reported
Research Site
Walnut Creek, California, United States
Site recruitment: Not reported
Research Site
Whittier, California, United States
Site recruitment: Not reported
Research Site
Colorado Springs, Colorado, United States
Site recruitment: Not reported
Research Site
Washington D.C., District of Columbia, United States
Site recruitment: Not reported
Research Site
Coral Gables, Florida, United States
Site recruitment: Not reported
Research Site
DeLand, Florida, United States
Site recruitment: Not reported
Research Site
Melbourne, Florida, United States
Site recruitment: Not reported
Research Site
Miami, Florida, United States
Site recruitment: Not reported
Research Site
New Port Richey, Florida, United States
Site recruitment: Not reported
Research Site
Decatur, Georgia, United States
Site recruitment: Not reported
Research Site
Avon, Indiana, United States
Site recruitment: Not reported
Research Site
Wichita, Kansas, United States
Site recruitment: Not reported
Research Site
Paducah, Kentucky, United States
Site recruitment: Not reported
Research Site
Baton Rouge, Louisiana, United States
Site recruitment: Not reported
Research Site
New Orleans, Louisiana, United States
Site recruitment: Not reported
Research Site
Oxon Hill, Maryland, United States
Site recruitment: Not reported
Research Site
Boston, Massachusetts, United States
Site recruitment: Not reported
Research Site
Chelsea, Michigan, United States
Site recruitment: Not reported
Research Site
Ypsilanti, Michigan, United States
Site recruitment: Not reported
Research Site
Saint Louis Park, Minnesota, United States
Site recruitment: Not reported
Research Site
St Louis, Missouri, United States
Site recruitment: Not reported
Research Site
Butte, Montana, United States
Site recruitment: Not reported
Research Site
Lincoln, Nebraska, United States
Site recruitment: Not reported
Research Site
Las Vegas, Nevada, United States
Site recruitment: Not reported
Research Site
New Hyde Park, New York, United States
Site recruitment: Not reported
Research Site
New Windsor, New York, United States
Site recruitment: Not reported
Research Site
New York, New York, United States
Site recruitment: Not reported
Research Site
Rochester, New York, United States
Site recruitment: Not reported
Research Site
Durham, North Carolina, United States
Site recruitment: Not reported
Research Site
Statesville, North Carolina, United States
Site recruitment: Not reported
Research Site
Winston-Salem, North Carolina, United States
Site recruitment: Not reported
Research Site
Athens, Ohio, United States
Site recruitment: Not reported
Research Site
Cincinnati, Ohio, United States
Site recruitment: Not reported
Research Site
Dayton, Ohio, United States
Site recruitment: Not reported
Research Site
Philadelphia, Pennsylvania, United States
Site recruitment: Not reported
Research Site
Rapid City, South Dakota, United States
Site recruitment: Not reported
Research Site
Memphis, Tennessee, United States
Site recruitment: Not reported
Research Site
Austin, Texas, United States
Site recruitment: Not reported
Research Site
Dallas, Texas, United States
Site recruitment: Not reported
Research Site
San Antonio, Texas, United States
Site recruitment: Not reported
Research Site
Richmond, Virginia, United States
Site recruitment: Not reported
Research Site
Olympia, Washington, United States
Site recruitment: Not reported
Research Site
Spokane, Washington, United States
Site recruitment: Not reported
Research Site
Tacoma, Washington, United States
Site recruitment: Not reported
Research Site
Bangalore, India
Site recruitment: Not reported
Research Site
Indore, India
Site recruitment: Not reported
Research Site
Karnāl, India
Site recruitment: Not reported
Research Site
Mumbai, India
Site recruitment: Not reported
Research Site
Pune, India
Site recruitment: Not reported
Research Site
Guadalajara, Jalisco, Mexico
Site recruitment: Not reported
Research Site
Zapopan, Jalisco, Mexico
Site recruitment: Not reported
Research Site
Mexico City, Mexico City, Mexico
Site recruitment: Not reported
Research Site
Cuernavaca, Morelos, Mexico
Site recruitment: Not reported
Research Site
Monterrey, NuevoLeon, Mexico
Site recruitment: Not reported
Research Site
Toluca, State of Mexico, Mexico
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 3CompletedINTERVENTIONAL

Exenatide Compared With Twice-Daily Biphasic Insulin Aspart in Patients With Type 2 Diabetes Using Sulfonylurea and Metformin

ClinicalTrials.gov · NCT00082407 · Registry updated: 2015-04-07

Condition / research focus: Diabetes Mellitus, Type 2
Sponsor: AstraZeneca
Countries with listed sites: Croatia · Germany · Greece · Italy · Netherlands · Portugal · Romania · Russia · Slovenia · Spain · Taiwan · United Kingdom
Registry dates and results: Start: 2003-11. Completion: 2008-07 (may be estimated). Results are posted in this registry.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

exenatide (drug) — also listed as: Byetta
biphasic insulin aspart (drug) — also listed as: NovoLog

Where the study takes place — 69 listed sites

Clinical Hospital Osijek
Osijek, Croatia
Site recruitment: Not reported
Klinica bolnica Dubrava
Zagreb, Croatia
Site recruitment: Not reported
Klinicki bolnicki centar Zagreb-Rebro
Zagreb, Croatia
Site recruitment: Not reported
Opca bolnica "Sveti Duh"
Zagreb, Croatia
Site recruitment: Not reported
Internistische Gemeinschaftspraxis
Augsburg, Germany
Site recruitment: Not reported
Dr. Karlheinz Hehemann
Beckum, Germany
Site recruitment: Not reported
Dr. Klaus Busch
Dortmund, Germany
Site recruitment: Not reported
Medical Clinic and Policlinic 3
Giessen, Germany
Site recruitment: Not reported
Diabetologische Schwerpunktpraxis
Hamburg, Germany
Site recruitment: Not reported
IKFE GmbH
Mainz, Germany
Site recruitment: Not reported
Institut for diabetic research
Munich, Germany
Site recruitment: Not reported
Profil, Institut fur Stoffwechselstorungen
Neuss, Germany
Site recruitment: Not reported
Dr. Thomas Behnke
Neuwied, Germany
Site recruitment: Not reported
Dr. Bernd Donaubauer
Oschatz, Germany
Site recruitment: Not reported
Marienhospital Osnabruck
Osnabrück, Germany
Site recruitment: Not reported
Dr. Joerg Steindorf
Schkeuditz, Germany
Site recruitment: Not reported
Dr. Jerzi Jasinski
Wiesbaden, Germany
Site recruitment: Not reported
"Polyclinic" General Hospital of Athens
Athens, Greece
Site recruitment: Not reported
Department of Endocrinology
Athens, Greece
Site recruitment: Not reported
Diabetes Center
Athens, Greece
Site recruitment: Not reported
University Hospital of Patras
Pátrai, Greece
Site recruitment: Not reported
1st Internal Medicine Department "Papagergiou"
Thessaloniki, Greece
Site recruitment: Not reported
Instituto di Endocrinologia
Catania, Italy
Site recruitment: Not reported
Dipartimento di fisiopatologia clinica
Florence, Italy
Site recruitment: Not reported
U.O. Medicina Generale
Milan, Italy
Site recruitment: Not reported
Ospedale Civile di Padova
Padova, Italy
Site recruitment: Not reported
Policlinico Univarsitario P. Giaccone
Palermo, Italy
Site recruitment: Not reported
U.O. Universita di Malattie del Metabolismo e Diabetologia
Torino, Italy
Site recruitment: Not reported
Gelre Ziekenhuizen
Apeldoorn, Netherlands
Site recruitment: Not reported
Rijnstate Ziekenhuis
Arnhem, Netherlands
Site recruitment: Not reported
Maxima Medisch Centrum Location Eindhoven
Eindhoven, Netherlands
Site recruitment: Not reported
Hospitais da Universidade de Coimbra
Coimbra, Portugal
Site recruitment: Not reported
Hospital de Santo Andre
Leiria, Portugal
Site recruitment: Not reported
Associacao Protectora dos Diabeticos de Portugal
Lisbon, Portugal
Site recruitment: Not reported
Hospital Pedro Hispano
Matosinhos Municipality, Portugal
Site recruitment: Not reported
Spitalul Judetean Brasov
Brasov, Romania
Site recruitment: Not reported
Institutul de Diabet
Bucharest, Romania
Site recruitment: Not reported
Spitalul Clinic nr. 1 Judetean
Judet Timis, Romania
Site recruitment: Not reported
National Endocrinology Research Center
Moscow, Russia
Site recruitment: Not reported
Setchenov Moscow Medical Academy
Moscow, Russia
Site recruitment: Not reported
Moscow State Medical Stomatological
Moscow, Russia
Site recruitment: Not reported
Russian Medical Academy for Advanced Medical Studies, Ministry of Health
Moscow, Russia
Site recruitment: Not reported
Hospital of St. Elizabeth's
Saint Petersburg, Russia
Site recruitment: Not reported
City Clinical Hospital #2
Saint Petersburg, Russia
Site recruitment: Not reported
Medical Military Academy
Saint Petersburg, Russia
Site recruitment: Not reported
Univerzitetni klinicni center Ljubljana
Ljubljana, Slovenia
Site recruitment: Not reported
Splosna bolnisnica Maribor
Maribor, Slovenia
Site recruitment: Not reported
Hospital Vega Baja
Alicante, Spain
Site recruitment: Not reported
Hospital Clinic i Provincial de Barcelona
Barcelona, Spain
Site recruitment: Not reported
Endocrinology Service (Planta Baja)
Palma de Mallorca, Spain
Site recruitment: Not reported
Hospital Virgen de Valme
Seville, Spain
Site recruitment: Not reported
Hospital General de Teruel
Teruel, Spain
Site recruitment: Not reported
Hospital la Ribera Alzira
Valencia, Spain
Site recruitment: Not reported
Changhua Christian Hospital
Changhua, Taiwan
Site recruitment: Not reported
Tzu Chi General Hospital
Hualien City, Taiwan
Site recruitment: Not reported
Veteran General Hospital-Taichung
Taichung, Taiwan
Site recruitment: Not reported
Tri-Service General Hospital
Taipei, Taiwan
Site recruitment: Not reported
Diabetes Research, Ward 34, Birmingham Heartlands Hospital
Birmingham, United Kingdom
Site recruitment: Not reported
Diabetes Unit, Blackburn Royal Infirmary
Blackburn, United Kingdom
Site recruitment: Not reported
Colchester General Hospital
Colchester, United Kingdom
Site recruitment: Not reported
Royal Infirmary of Edinburgh
Edinburgh, United Kingdom
Site recruitment: Not reported
Glasgow Royal Infirmary
Glasgow, United Kingdom
Site recruitment: Not reported
The Michael White Center for Diabetes and Endocrinology
Hull, United Kingdom
Site recruitment: Not reported
Clinical Sciences Centre
Liverpool, United Kingdom
Site recruitment: Not reported
Education Centre, James Cook University Hospital
Middlesbrough, United Kingdom
Site recruitment: Not reported
Wellcome Labs, Royal Victoria Infirmary
Newcastle upon Tyne, United Kingdom
Site recruitment: Not reported
Queens Medical Centre
Nottingham, United Kingdom
Site recruitment: Not reported
Diabetes Trial Unit OCDEM, Churchill Hospital
Oxford, United Kingdom
Site recruitment: Not reported
Diabetes Unit, Gladsone Centre, Maelor Hospital
Wrexham, United Kingdom
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 3CompletedINTERVENTIONAL

A Study to Evaluate the Glycemic Effects, Safety, and Tolerability of Exenatide Once Weekly in Subjects With Type 2 Diabetes Mellitus (DURATION-5)

ClinicalTrials.gov · NCT00877890 · Registry updated: 2015-04-07

Condition / research focus: Type 2 Diabetes Mellitus
Sponsor: AstraZeneca
Countries with listed sites: United States
Registry dates and results: Start: 2009-03. Completion: 2010-01 (may be estimated). Results are posted in this registry.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

exenatide once weekly (drug) — also listed as: BYDUREON
exenatide twice daily (drug) — also listed as: BYETTA

Where the study takes place — 41 listed sites

Research Site
Birmingham, Alabama, United States
Site recruitment: Not reported
Research Site
Mesa, Arizona, United States
Site recruitment: Not reported
Research Site
Peoria, Arizona, United States
Site recruitment: Not reported
Research Site
Artesia, California, United States
Site recruitment: Not reported
Research Site
Concord, California, United States
Site recruitment: Not reported
Research Site
Encino, California, United States
Site recruitment: Not reported
Research Site
Greenbrae, California, United States
Site recruitment: Not reported
Research Site
La Mesa, California, United States
Site recruitment: Not reported
Research Site
Walnut Creek, California, United States
Site recruitment: Not reported
Research Site
DeLand, Florida, United States
Site recruitment: Not reported
Research Site
Hialeah, Florida, United States
Site recruitment: Not reported
Research Site
Miami, Florida, United States
Site recruitment: Not reported
Research Site
New Port Richey, Florida, United States
Site recruitment: Not reported
Research Site
Palm Harbor, Florida, United States
Site recruitment: Not reported
Research Site
Chicago, Illinois, United States
Site recruitment: Not reported
Research Site
Avon, Indiana, United States
Site recruitment: Not reported
Research Site
Evansville, Indiana, United States
Site recruitment: Not reported
Research Site
Lexington, Kentucky, United States
Site recruitment: Not reported
Research Site
Paducah, Kentucky, United States
Site recruitment: Not reported
Research Site
Detroit, Michigan, United States
Site recruitment: Not reported
Research Site
Edina, Minnesota, United States
Site recruitment: Not reported
Research Site
St Louis, Missouri, United States
Site recruitment: Not reported
Research Site
Butte, Montana, United States
Site recruitment: Not reported
Research Site
New Hyde Park, New York, United States
Site recruitment: Not reported
Research Site
Rochester, New York, United States
Site recruitment: Not reported
Research Site
Raleigh, North Carolina, United States
Site recruitment: Not reported
Research Site
Statesville, North Carolina, United States
Site recruitment: Not reported
Research Site
Cincinnati, Ohio, United States
Site recruitment: Not reported
Research Site
Delaware, Ohio, United States
Site recruitment: Not reported
Research Site
Mentor, Ohio, United States
Site recruitment: Not reported
Research Site
Eugene, Oregon, United States
Site recruitment: Not reported
Research Site
Rapid City, South Dakota, United States
Site recruitment: Not reported
Research Site
Austin, Texas, United States
Site recruitment: Not reported
Research Site
Corpus Christi, Texas, United States
Site recruitment: Not reported
Research Site
San Antonio, Texas, United States
Site recruitment: Not reported
Research Site
Burke, Virginia, United States
Site recruitment: Not reported
Research Site
Manassas, Virginia, United States
Site recruitment: Not reported
Research Site
Richmond, Virginia, United States
Site recruitment: Not reported
Research Site
Olympia, Washington, United States
Site recruitment: Not reported
Research Site
Spokane, Washington, United States
Site recruitment: Not reported
Research Site
Tacoma, Washington, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 3CompletedINTERVENTIONAL

Efficacy of Once-Weekly Exenatide Versus Once or Twice Daily Insulin Detemir in Patients With Type 2 Diabetes

ClinicalTrials.gov · NCT01003184 · Registry updated: 2015-04-07

Condition / research focus: Type 2 Diabetes Mellitus
Sponsor: AstraZeneca
Countries with listed sites: Ireland · United Kingdom
Registry dates and results: Start: 2009-10. Completion: 2011-12 (may be estimated). Results are posted in this registry.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

exenatide once weekly (drug)
insulin detemir (drug) — also listed as: Levemir

Where the study takes place — 34 listed sites

Research Site
Dublin, Ireland
Site recruitment: Not reported
Research Site
Addlestone, England, United Kingdom
Site recruitment: Not reported
Research Site
Bath, England, United Kingdom
Site recruitment: Not reported
Research Site
Birmingham, England, United Kingdom
Site recruitment: Not reported
Research Site
Blackburn, England, United Kingdom
Site recruitment: Not reported
Research Site
Bournemouth, England, United Kingdom
Site recruitment: Not reported
Research Site
Chippenham, England, United Kingdom
Site recruitment: Not reported
Research Site
Derby, England, United Kingdom
Site recruitment: Not reported
Research Site
Exeter, England, United Kingdom
Site recruitment: Not reported
Research Site
High Wycombe, England, United Kingdom
Site recruitment: Not reported
Research Site
Hull, England, United Kingdom
Site recruitment: Not reported
Research Site
Leicester, England, United Kingdom
Site recruitment: Not reported
Research Site
Liverpool, England, United Kingdom
Site recruitment: Not reported
Research Site
London, England, United Kingdom
Site recruitment: Not reported
Research Site
Manchester, England, United Kingdom
Site recruitment: Not reported
Research Site
Merseyside, England, United Kingdom
Site recruitment: Not reported
Research Site
Middlesbrough, England, United Kingdom
Site recruitment: Not reported
Research Site
Newcastle, England, United Kingdom
Site recruitment: Not reported
Research Site
Northampton, England, United Kingdom
Site recruitment: Not reported
Research Site
Oldham, England, United Kingdom
Site recruitment: Not reported
Research Site
Plymouth, England, United Kingdom
Site recruitment: Not reported
Research Site
Portsmouth, England, United Kingdom
Site recruitment: Not reported
Research Site
Sheffield, England, United Kingdom
Site recruitment: Not reported
Research Site
Stevenage, England, United Kingdom
Site recruitment: Not reported
Research Site
Suffolk, England, United Kingdom
Site recruitment: Not reported
Research Site
Wakefield, England, United Kingdom
Site recruitment: Not reported
Research Site
Wiltshire, England, United Kingdom
Site recruitment: Not reported
Research Site
Aberdeen, Scotland, United Kingdom
Site recruitment: Not reported
Research Site
Dundee, Scotland, United Kingdom
Site recruitment: Not reported
Research Site
Carmathen, Wales, United Kingdom
Site recruitment: Not reported
Research Site
Swansea, Wales, United Kingdom
Site recruitment: Not reported
Research Site
Wrexham, Wales, United Kingdom
Site recruitment: Not reported
Research Site
Leytonstone, United Kingdom
Site recruitment: Not reported
Research Site
Livingston, United Kingdom
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 3CompletedINTERVENTIONAL

A Study Comparing Exenatide With Basal Insulin in Achieving a Target HbA1c With Minimum Weight Gain in Type 2 Diabetes Patients

ClinicalTrials.gov · NCT00360334 · Registry updated: 2015-04-07

Condition / research focus: Type 2 Diabetes
Sponsor: AstraZeneca
Countries with listed sites: United Kingdom
Registry dates and results: Start: 2006-06. Completion: 2008-04 (may be estimated). Results are posted in this registry.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

exenatide (drug) — also listed as: Byetta
insulin glargine (drug) — also listed as: Lantus

Where the study takes place — 31 listed sites

Research Site
Aberdeen, United Kingdom
Site recruitment: Not reported
Research Site
Bath, United Kingdom
Site recruitment: Not reported
Research Site
Blackburn, United Kingdom
Site recruitment: Not reported
Research Site
Bolton, United Kingdom
Site recruitment: Not reported
Research Site
Bournemouth, United Kingdom
Site recruitment: Not reported
Research Site
Bristol, United Kingdom
Site recruitment: Not reported
Research Site
Chippenham, United Kingdom
Site recruitment: Not reported
Research Site
Edinburgh, United Kingdom
Site recruitment: Not reported
Research Site
Glasgow, United Kingdom
Site recruitment: Not reported
Research Site
Haywards Heath, United Kingdom
Site recruitment: Not reported
Research Site
High Wycombe, United Kingdom
Site recruitment: Not reported
Research Site
Hull, United Kingdom
Site recruitment: Not reported
Research Site
Ipswich, United Kingdom
Site recruitment: Not reported
Research Site
Kent, United Kingdom
Site recruitment: Not reported
Research Site
Leicester, United Kingdom
Site recruitment: Not reported
Research Site
Liverpool, United Kingdom
Site recruitment: Not reported
Research Site
Livingstone, United Kingdom
Site recruitment: Not reported
Research Site
London, United Kingdom
Site recruitment: Not reported
Research Site
Manchester, United Kingdom
Site recruitment: Not reported
Research Site
Metropolitan Borough of Wirral, United Kingdom
Site recruitment: Not reported
Research Site
Middlesbrough, United Kingdom
Site recruitment: Not reported
Research Site
Norwich, United Kingdom
Site recruitment: Not reported
Research Site
Nottingham, United Kingdom
Site recruitment: Not reported
Research Site
Oldham, United Kingdom
Site recruitment: Not reported
Research Site
Oxford, United Kingdom
Site recruitment: Not reported
Research Site
Plymouth, United Kingdom
Site recruitment: Not reported
Research Site
Rochdale, United Kingdom
Site recruitment: Not reported
Research Site
Salford, United Kingdom
Site recruitment: Not reported
Research Site
Swansea, United Kingdom
Site recruitment: Not reported
Research Site
Torquay, United Kingdom
Site recruitment: Not reported
Research Site
Wakefield, United Kingdom
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Explore the world’s study registries

These links open external registries; their records are not merged into the results above. WHO ICTRP provides a broader search across contributing registries. Search the same generic name, aliases and development codes in relevant regions. One multinational study may appear in more than one registry, so compare registration identifiers before counting it twice.

Worldwide

Africa

Pan African Clinical Trial Registry ↗

Americas

Asia

Middle East

Europe

Oceania

Australia / New Zealand — ANZCTR ↗

Registry directory checked October 5, 2026 against the WHO registry network. This is a starting point, not complete coverage of every country or continent. Record availability, language and update schedules vary by registry.

Worldwide Study Finder

Loading registry information…

Worldwide Study Finder

Where are peptides being studied? Explore registered human studies by product, phase, condition and location — from early development through Phase 4, alongside studies where phase does not apply.

Searchable results come from ClinicalTrials.gov and include international sites. For broader coverage, use the worldwide and regional registries below. No single registry captures every study.

Find a study

Registry search results

Matching records; showing 20 on this page, newest registry updates first. Search checked 2026-10-08 04:18 UTC. Counts are registry matches, not unique peptides or a worldwide total.

Phase not reported / not applicableCompletedOBSERVATIONAL

CHOICE: CHanges to Treatment and Outcomes in Patients With Type 2 Diabetes Initiating InjeCtablE Therapy

ClinicalTrials.gov · NCT00635492 · Registry updated: 2015-04-09

Condition / research focus: Type 2 Diabetes Mellitus
Sponsor: AstraZeneca
Countries with listed sites: Denmark · France · Germany · Greece · Sweden
Registry dates and results: Start: 2008-01. Completion: 2011-12 (may be estimated). Results are posted in this registry.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

exenatide (drug) — also listed as: Byetta
any human insulin or analog insulin(s) given in any regimen by subcutaneous injection (drug)

Where the study takes place — 96 listed sites

Research Site
Amager, Denmark
Site recruitment: Not reported
Research Site
Rønne, Denmark
Site recruitment: Not reported
Research Site
Toul, France
Site recruitment: Not reported
Research Site
Alsfeld, Germany
Site recruitment: Not reported
Research
Aschaffenburg, Germany
Site recruitment: Not reported
Research Site
Augsburg, Germany
Site recruitment: Not reported
Research Site
Aßlar, Germany
Site recruitment: Not reported
Research Site
Bad Aibling, Germany
Site recruitment: Not reported
Research Site
Bad Homburg, Germany
Site recruitment: Not reported
Research Site
Bad Mergentheim, Germany
Site recruitment: Not reported
Research Site
Bergheim, Germany
Site recruitment: Not reported
Research Site
Berlin, Germany
Site recruitment: Not reported
Research
Birkenfeld, Germany
Site recruitment: Not reported
Research Site
Bosenheim, Germany
Site recruitment: Not reported
Research Site
Bruchsal, Germany
Site recruitment: Not reported
Research Site
Dortmund, Germany
Site recruitment: Not reported
Research Site
Dresden, Germany
Site recruitment: Not reported
Research Site
Duisburg, Germany
Site recruitment: Not reported
Research Site
Eberswalde, Germany
Site recruitment: Not reported
Research Site
Eilenburg, Germany
Site recruitment: Not reported
Research Site
Eisenach, Germany
Site recruitment: Not reported
Research Site
Erfurt, Germany
Site recruitment: Not reported
Research Site
Essen, Germany
Site recruitment: Not reported
Research Site
Frankfurt, Germany
Site recruitment: Not reported
Research Site
Gebhardshain, Germany
Site recruitment: Not reported
Research Site
Gersfeld, Germany
Site recruitment: Not reported
Research Site
Giessen, Germany
Site recruitment: Not reported
Research Site
Gifhorn, Germany
Site recruitment: Not reported
Research Site
Grassau, Germany
Site recruitment: Not reported
Research Site
Groß-Gerau, Germany
Site recruitment: Not reported
Research Site
Hadmersleben, Germany
Site recruitment: Not reported
Research Site
Halle, Germany
Site recruitment: Not reported
Research Site
Hamburg, Germany
Site recruitment: Not reported
Research Site
Hammelburg, Germany
Site recruitment: Not reported
Research Site
Hennigsdorf, Germany
Site recruitment: Not reported
Research Site
Hohenmölsen, Germany
Site recruitment: Not reported
Research Site
Ismaning, Germany
Site recruitment: Not reported
Research Site
Köthen, Germany
Site recruitment: Not reported
Research Site
Kutenholz, Germany
Site recruitment: Not reported
Research Site
Langen, Germany
Site recruitment: Not reported
Research Site
Langenfeld, Germany
Site recruitment: Not reported
Research Site
Leipzig, Germany
Site recruitment: Not reported
Research Site
Lichtenfels, Germany
Site recruitment: Not reported
Research Site
Ludwigsburg, Germany
Site recruitment: Not reported
Research Site
Lüneburg, Germany
Site recruitment: Not reported
Research Site
Marburg, Germany
Site recruitment: Not reported
Research Site
Mayen, Germany
Site recruitment: Not reported
Research Site
Meissen, Germany
Site recruitment: Not reported
Research Site
Minden, Germany
Site recruitment: Not reported
Research Site
Mönchengladbach, Germany
Site recruitment: Not reported
Research Site
München, Germany
Site recruitment: Not reported
Research Site
Münster, Germany
Site recruitment: Not reported
Research Site
Nassau, Germany
Site recruitment: Not reported
Research Site
Netphen, Germany
Site recruitment: Not reported
Research Site
Oberhausen, Germany
Site recruitment: Not reported
Research Site
Pirmasens, Germany
Site recruitment: Not reported
Research Site
Recklinghausen, Germany
Site recruitment: Not reported
Research Site
Rehburg-Loccum, Germany
Site recruitment: Not reported
Research Site
Reichenbach, Germany
Site recruitment: Not reported
Research Site
Riesa, Germany
Site recruitment: Not reported
Research Site
Saarbrücken, Germany
Site recruitment: Not reported
Research Site
Saarlouis, Germany
Site recruitment: Not reported
Research Site
Schkeuditz, Germany
Site recruitment: Not reported
Research Site
Schönwalde, Germany
Site recruitment: Not reported
Research Site
Schweinfurt, Germany
Site recruitment: Not reported
Research Site
Seligenstadt, Germany
Site recruitment: Not reported
Research Site
Siegen, Germany
Site recruitment: Not reported
Research Site
Stockach, Germany
Site recruitment: Not reported
Research Site
Thale, Germany
Site recruitment: Not reported
Research Site
Ueckermünde, Germany
Site recruitment: Not reported
Research Site
Übach-Palenberg, Germany
Site recruitment: Not reported
Research Site
Villingen-Schwenningen, Germany
Site recruitment: Not reported
Research Site
Völklingen, Germany
Site recruitment: Not reported
Research Site
Warburg, Germany
Site recruitment: Not reported
Research Site
Weißenberg, Germany
Site recruitment: Not reported
Research Site
Werl, Germany
Site recruitment: Not reported
Research Site
Westfalica, Germany
Site recruitment: Not reported
Research Site
Wilhelmshaven, Germany
Site recruitment: Not reported
Research Site
Wurzen, Germany
Site recruitment: Not reported
Research Site
Kozani, Greece
Site recruitment: Not reported
Research Site
N. Efkarpia, Greece
Site recruitment: Not reported
Research Site
Thessaloniki, Greece
Site recruitment: Not reported
Research Site
Véroia, Greece
Site recruitment: Not reported
Research Site
Angered, Sweden
Site recruitment: Not reported
Research Site
Ängelholm, Sweden
Site recruitment: Not reported
Research Site
Dalby, Sweden
Site recruitment: Not reported
Research Site
Falun, Sweden
Site recruitment: Not reported
Research Site
Gothenburg, Sweden
Site recruitment: Not reported
Research Site
Limhamn, Sweden
Site recruitment: Not reported
Research Site
Luleå, Sweden
Site recruitment: Not reported
Research Site
Malmö, Sweden
Site recruitment: Not reported
Research Site
Skivarp, Sweden
Site recruitment: Not reported
Research Site
Skövde, Sweden
Site recruitment: Not reported
Research Site
Stockholm, Sweden
Site recruitment: Not reported
Research Site
Vadstena, Sweden
Site recruitment: Not reported
Research Site
Västervik, Sweden
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 4CompletedINTERVENTIONAL

Comparison of the Effect of Exenatide Versus Sitagliptin on 24-hour Average Glucose in Patients With Type 2 Diabetes on Metformin or a Thiazolidinedione

ClinicalTrials.gov · NCT00729326 · Registry updated: 2015-04-09

Condition / research focus: Type 2 Diabetes Mellitus
Sponsor: AstraZeneca
Countries with listed sites: United States
Registry dates and results: Start: 2008-08. Completion: 2009-10 (may be estimated). Results are posted in this registry.

Products and interventions (4)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

exenatide (drug) — also listed as: Byetta
sitagliptin (drug) — also listed as: Januvia
placebo (drug)
placebo (drug)

Where the study takes place — 1 listed sites

Research Site
San Antonio, Texas, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase not reported / not applicableCompletedOBSERVATIONAL

Exenatide and Basal Insulins Use in the Real Setting: an Observational Study in Patients With Type 2 Diabetes

ClinicalTrials.gov · NCT01060059 · Registry updated: 2015-04-09

Condition / research focus: Type 2 Diabetes Mellitus
Sponsor: AstraZeneca
Countries with listed sites: Italy
Registry dates and results: Start: 2010-04. Completion: 2012-05 (may be estimated). Results are posted in this registry.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

exenatide (drug) — also listed as: BYETTA
basal insulin (drug)

Where the study takes place — 50 listed sites

Research site
Acquaviva delle Fonti, Italy
Site recruitment: Not reported
Research site
Anzio, Italy
Site recruitment: Not reported
Research site
Bassano del Grappa, Italy
Site recruitment: Not reported
Research site
Bologna, Italy
Site recruitment: Not reported
Research site
Brindisi, Italy
Site recruitment: Not reported
Research site
Cagliari, Italy
Site recruitment: Not reported
Research site
Campi Salentina, Italy
Site recruitment: Not reported
Research site
Casarano, Italy
Site recruitment: Not reported
Research site
Caserta, Italy
Site recruitment: Not reported
Research site
Cesena, Italy
Site recruitment: Not reported
Research site
Chieri, Italy
Site recruitment: Not reported
Research site
Cisternino, Italy
Site recruitment: Not reported
Research site
Copertino, Italy
Site recruitment: Not reported
Research site
Cremona, Italy
Site recruitment: Not reported
Research site
Distretto Vittoria, Italy
Site recruitment: Not reported
Research site
Fermo, Italy
Site recruitment: Not reported
Research site
Ferrara, Italy
Site recruitment: Not reported
Research site
Fidenza, Italy
Site recruitment: Not reported
Research site
Florence, Italy
Site recruitment: Not reported
Research site
Forlì, Italy
Site recruitment: Not reported
Research site
Genova, Italy
Site recruitment: Not reported
Research site
Germaneto, Italy
Site recruitment: Not reported
Research site
Lecce, Italy
Site recruitment: Not reported
Research site
Livorno, Italy
Site recruitment: Not reported
Research site
Lucca, Italy
Site recruitment: Not reported
Research site
Manfredonia (Le), Italy
Site recruitment: Not reported
Research site
Mariano Comense, Italy
Site recruitment: Not reported
Research site
Messina, Italy
Site recruitment: Not reported
Research site
Milan, Italy
Site recruitment: Not reported
Research site
Monza, Italy
Site recruitment: Not reported
Research site
Naples, Italy
Site recruitment: Not reported
Research site
Novara, Italy
Site recruitment: Not reported
Research site
Olbia, Italy
Site recruitment: Not reported
Research site
Palermo, Italy
Site recruitment: Not reported
Research site
Palmi, Italy
Site recruitment: Not reported
Research site
Parma, Italy
Site recruitment: Not reported
Research site
Pavia, Italy
Site recruitment: Not reported
Research site
Pisa, Italy
Site recruitment: Not reported
Research site
Potenza, Italy
Site recruitment: Not reported
Research site
Rimini, Italy
Site recruitment: Not reported
Research site
Roma, Italy
Site recruitment: Not reported
Research site
Rossano Scalo, Italy
Site recruitment: Not reported
Research site
Salerno, Italy
Site recruitment: Not reported
Research site
San Giovanni Rotondo, Italy
Site recruitment: Not reported
Research site
Schio, Italy
Site recruitment: Not reported
Research site
Sesto San Giovanni, Italy
Site recruitment: Not reported
Research site
Siena, Italy
Site recruitment: Not reported
Research site
Treviso, Italy
Site recruitment: Not reported
Research site
Trieste, Italy
Site recruitment: Not reported
Research site
Varese, Italy
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 3CompletedINTERVENTIONAL

Safety and Efficacy of Exenatide Once Weekly Injection Versus Metformin, Dipeptidyl Peptidase-4 Inhibitor, or Thiazolidinedione as Monotherapy in Drug-Naive Patients With Type 2 Diabetes (DURATION-4)

ClinicalTrials.gov · NCT00676338 · Registry updated: 2015-04-09

Condition / research focus: Type 2 Diabetes Mellitus
Sponsor: AstraZeneca
Countries with listed sites: Argentina · Belgium · Brazil · Canada · France · Germany · Hungary · India · Israel · Italy · Mexico · Poland · Puerto Rico · Romania · Russia · Slovakia · South Africa · South Korea · Spain · Turkey (Türkiye) · United Kingdom · United States
Registry dates and results: Start: 2008-11. Completion: 2011-01 (may be estimated). Results are posted in this registry.

Products and interventions (4)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

exenatide once weekly (drug)
metformin (drug)
sitagliptin (drug)
pioglitazone (drug)

Where the study takes place — 106 listed sites

Research Site
Buena Park, California, United States
Site recruitment: Not reported
Research Site
Los Angeles, California, United States
Site recruitment: Not reported
Research Site
Valencia, California, United States
Site recruitment: Not reported
Research Site
Jacksonville, Florida, United States
Site recruitment: Not reported
Research Site
Atlanta, Georgia, United States
Site recruitment: Not reported
Research Site
Meridian, Idaho, United States
Site recruitment: Not reported
Research Site
Des Moines, Iowa, United States
Site recruitment: Not reported
Research Site
Grand Rapids, Michigan, United States
Site recruitment: Not reported
Research Site
Minneapolis, Minnesota, United States
Site recruitment: Not reported
Research Site
Billings, Montana, United States
Site recruitment: Not reported
Research Site
Toms River, New Jersey, United States
Site recruitment: Not reported
Research Site
Wilmington, North Carolina, United States
Site recruitment: Not reported
Research Site
Danville, Pennsylvania, United States
Site recruitment: Not reported
Research Site
Philadelphia, Pennsylvania, United States
Site recruitment: Not reported
Research Site
Wilke Barre, Pennsylvania, United States
Site recruitment: Not reported
Research Site
Austin, Texas, United States
Site recruitment: Not reported
Research Site
El Paso, Texas, United States
Site recruitment: Not reported
Research Site
New Branufels, Texas, United States
Site recruitment: Not reported
Research Site
Buenos Aires, Argentina
Site recruitment: Not reported
Research Site
Mar del Plata, Argentina
Site recruitment: Not reported
Research Site
Leuven, Belgium
Site recruitment: Not reported
Research Site
Marchovelette, Belgium
Site recruitment: Not reported
Research Site
Tessenderlo, Belgium
Site recruitment: Not reported
Research Site
Brasília, Brazil
Site recruitment: Not reported
Research Site
Campinas, Brazil
Site recruitment: Not reported
Research Site
Curitiba, Brazil
Site recruitment: Not reported
Research Site
Fortaleza, Brazil
Site recruitment: Not reported
Research Site
Joinville, Brazil
Site recruitment: Not reported
Research SIte
Porto Alegre, Brazil
Site recruitment: Not reported
Research Site
Recife, Brazil
Site recruitment: Not reported
Research Site
São Paulo, Brazil
Site recruitment: Not reported
Research Site
Coquitlam, British Columbia, Canada
Site recruitment: Not reported
Research Site
Penticton, British Columbia, Canada
Site recruitment: Not reported
Research Site
Ottawa, Ontario, Canada
Site recruitment: Not reported
Research Site
Gatineu, Quebec, Canada
Site recruitment: Not reported
Research Site
Mississauga, Canada
Site recruitment: Not reported
Research Site
Petitcodiac, Canada
Site recruitment: Not reported
Research Site
Pointe-Claire, Canada
Site recruitment: Not reported
Research Site
Regina, Canada
Site recruitment: Not reported
Research Site
Saint John, Canada
Site recruitment: Not reported
Research Site
Châteaugiron, France
Site recruitment: Not reported
Research Site
Mûrs-Erigné, France
Site recruitment: Not reported
Research Site
Nantes, France
Site recruitment: Not reported
Research Site
Vieux-Condé, France
Site recruitment: Not reported
Research Site
Dresden, Germany
Site recruitment: Not reported
Research Site
Mainz, Germany
Site recruitment: Not reported
Research Site
Münster, Germany
Site recruitment: Not reported
Research Site
Rodgau, Germany
Site recruitment: Not reported
Research Site
Budapest, Hungary
Site recruitment: Not reported
Research Site
Gyula, Hungary
Site recruitment: Not reported
Research Site
Hódmezővásárhely, Hungary
Site recruitment: Not reported
Research Site
Pécs, Hungary
Site recruitment: Not reported
Research Site
Ahmedabad, India
Site recruitment: Not reported
Research Site
Bangalore, India
Site recruitment: Not reported
Research Site
Channai, India
Site recruitment: Not reported
Research Site
Kochi, India
Site recruitment: Not reported
Research Site
Mumbai, India
Site recruitment: Not reported
Research Site
New Dehli, India
Site recruitment: Not reported
Research SIte
Pune, India
Site recruitment: Not reported
Research Site
Holon, Israel
Site recruitment: Not reported
Research SIte
Tel Litwinsky, Israel
Site recruitment: Not reported
Research Site
Florence, Italy
Site recruitment: Not reported
Research Site
Milan, Italy
Site recruitment: Not reported
Research Site
Siena, Italy
Site recruitment: Not reported
Research Site
Chihuahua City, Mexico
Site recruitment: Not reported
Research Site
Guadalajara, Mexico
Site recruitment: Not reported
Research Site
Monterrey, Mexico
Site recruitment: Not reported
Research Site
Lublin, Poland
Site recruitment: Not reported
Research Site
Szczecin, Poland
Site recruitment: Not reported
Research Site
Wroclaw, Poland
Site recruitment: Not reported
Research Site
Manati, Puerto Rico
Site recruitment: Not reported
Research Site
Toa Baja, Puerto Rico
Site recruitment: Not reported
Research Site
Galati, Romania
Site recruitment: Not reported
Research Site
Oradea, Romania
Site recruitment: Not reported
Research Site
Târgu Mureş, Romania
Site recruitment: Not reported
Research Site
Arkhangelsk, Russia
Site recruitment: Not reported
Research Site
Moscow, Russia
Site recruitment: Not reported
Research Site
Rostov-on-Don, Russia
Site recruitment: Not reported
Research Site
Saint Petersburg, Russia
Site recruitment: Not reported
Research Site
Stavropol, Russia
Site recruitment: Not reported
Research Site
Bratislava, Slovakia
Site recruitment: Not reported
Research Site
Trebišov, Slovakia
Site recruitment: Not reported
Research Site
Johannesburg, South Africa
Site recruitment: Not reported
Research Site
Kempton Park, South Africa
Site recruitment: Not reported
Research Site
Midrand, South Africa
Site recruitment: Not reported
Research Site
Soweto, South Africa
Site recruitment: Not reported
Research Site
Busan, South Korea
Site recruitment: Not reported
Research Site
Daegu, South Korea
Site recruitment: Not reported
Research Site
Jeonju, South Korea
Site recruitment: Not reported
Research Site
Seoul, South Korea
Site recruitment: Not reported
Research Site
Sungnam, South Korea
Site recruitment: Not reported
Research Site
Alicante, Spain
Site recruitment: Not reported
Research Site
Barcelona, Spain
Site recruitment: Not reported
Research Site
Madrid, Spain
Site recruitment: Not reported
Research Site
Seville, Spain
Site recruitment: Not reported
Research Site
Ankara, Turkey (Türkiye)
Site recruitment: Not reported
Research Site
Istanbul, Turkey (Türkiye)
Site recruitment: Not reported
Research Site
Sisli-Istanbul, Turkey (Türkiye)
Site recruitment: Not reported
Research Site
Bath, United Kingdom
Site recruitment: Not reported
Research Site
Birmingham, United Kingdom
Site recruitment: Not reported
Research Site
Edinburgh, United Kingdom
Site recruitment: Not reported
Research Site
Frome, United Kingdom
Site recruitment: Not reported
Research Site
Guildford, United Kingdom
Site recruitment: Not reported
Research Site
Hull, United Kingdom
Site recruitment: Not reported
Research Site
Sheffield, United Kingdom
Site recruitment: Not reported
Research Site
Swansea, United Kingdom
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 4CompletedINTERVENTIONAL

A Comparison of Adding Exenatide With Switching to Exenatide in Patients With Type 2 Diabetes Experiencing Inadequate Glycemic Control With Sitagliptin Plus Metformin

ClinicalTrials.gov · NCT00870194 · Registry updated: 2015-04-09

Condition / research focus: Type 2 Diabetes Mellitus
Sponsor: AstraZeneca
Countries with listed sites: Argentina · Australia · Germany · Greece · India · Mexico · South Korea
Registry dates and results: Start: 2009-03. Completion: 2010-04 (may be estimated). Results are posted in this registry.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

exenatide and sitagliptin (drug) — also listed as: exenatide-Byetta; sitagliptin-Januvia
exenatide and placebo (drug) — also listed as: exenatide-Byetta

Where the study takes place — 36 listed sites

Research Site
Buenos Aires, Argentina
Site recruitment: Not reported
Research Site
Morón, Argentina
Site recruitment: Not reported
Research Site
Adelaide, Australia
Site recruitment: Not reported
Research Site
Geelong, Australia
Site recruitment: Not reported
Research Site
Melbourne, Australia
Site recruitment: Not reported
Research Site
Aschaffenburg, Germany
Site recruitment: Not reported
Research Site
Aßlar, Germany
Site recruitment: Not reported
Research Site
Beckum-Neubeckum, Germany
Site recruitment: Not reported
Research Site
Berlin, Germany
Site recruitment: Not reported
Research Site
Bosenheim, Germany
Site recruitment: Not reported
Research Site
Essen, Germany
Site recruitment: Not reported
Research Site
Falkensee, Germany
Site recruitment: Not reported
Research Site
Furth im Wald, Germany
Site recruitment: Not reported
Research Site
Grevenbroich, Germany
Site recruitment: Not reported
Research Site
Hohenmölsen, Germany
Site recruitment: Not reported
Research Site
Leipzig, Germany
Site recruitment: Not reported
Research Site
Neuwied, Germany
Site recruitment: Not reported
Research Site
Othmarschen, Germany
Site recruitment: Not reported
Research Site
Pohlheim, Germany
Site recruitment: Not reported
Research Site
Speyer, Germany
Site recruitment: Not reported
Research Site
Athens, Greece
Site recruitment: Not reported
Research Site
Thessaloniki, Greece
Site recruitment: Not reported
Research Site
Ahmedabad, India
Site recruitment: Not reported
Research Site
Bangalore, India
Site recruitment: Not reported
Research Site
Coimbatore, India
Site recruitment: Not reported
Research Site
Indore, India
Site recruitment: Not reported
Research Site
Jaipur, India
Site recruitment: Not reported
Research Site
Coatzacoalcos, Mexico
Site recruitment: Not reported
Research Site
Guadalajara, Mexico
Site recruitment: Not reported
Research Site
Mérida, Mexico
Site recruitment: Not reported
Research Site
Monterrey, Mexico
Site recruitment: Not reported
Research Site
Tampico, Mexico
Site recruitment: Not reported
Research Site
Daegu, South Korea
Site recruitment: Not reported
Research Site
Gwangju, South Korea
Site recruitment: Not reported
Research Site
Seoul, South Korea
Site recruitment: Not reported
Research Site
Ulsan, South Korea
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 3CompletedINTERVENTIONAL

A Study to Examine the Effects of Exenatide Once-Weekly Injection on Glucose Control and Safety in Asian Subjects

ClinicalTrials.gov · NCT00917267 · Registry updated: 2015-04-09

Condition / research focus: Type 2 Diabetes Mellitus
Sponsor: AstraZeneca
Countries with listed sites: China · India · Japan · South Korea · Taiwan
Registry dates and results: Start: 2009-07. Completion: 2011-04 (may be estimated). Results are posted in this registry.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

exenatide once weekly (drug)
exenatide twice daily (drug) — also listed as: Byetta

Where the study takes place — 42 listed sites

Research Site
Beijing, China
Site recruitment: Not reported
Research Site
Chengdu, China
Site recruitment: Not reported
Research Site
Chongqin, China
Site recruitment: Not reported
Research Site
Guangzhou, China
Site recruitment: Not reported
Research Site
Shanghai, China
Site recruitment: Not reported
Research Site
Ahmedabad, India
Site recruitment: Not reported
Research Site
Aligarh, India
Site recruitment: Not reported
Research Site
Bangalore, India
Site recruitment: Not reported
Research Site
Ghaziabad, India
Site recruitment: Not reported
Research Site
Hyderabaad, India
Site recruitment: Not reported
Research Site
Indore, India
Site recruitment: Not reported
Research Site
Kolkata, India
Site recruitment: Not reported
Research Site
Mumbai, India
Site recruitment: Not reported
Research Site
Pune, India
Site recruitment: Not reported
Research Site
Trivandrum, India
Site recruitment: Not reported
Research Site
Uttar Pradesh, India
Site recruitment: Not reported
Research Site
Varanasi, India
Site recruitment: Not reported
Research Site
Ageo, Japan
Site recruitment: Not reported
Research Site
Chiyoda-ku, Japan
Site recruitment: Not reported
Research Site
Izumisano, Japan
Site recruitment: Not reported
Research Site
Kashiwara, Japan
Site recruitment: Not reported
Research Site
Kitaazumi-gun, Japan
Site recruitment: Not reported
Research Site
Kumamoto, Japan
Site recruitment: Not reported
Research Site
Kurume, Japan
Site recruitment: Not reported
Research Site
Matsumoto, Japan
Site recruitment: Not reported
Research Site
Matsuyama, Japan
Site recruitment: Not reported
Research Site
Miyazaki, Japan
Site recruitment: Not reported
Research Site
Osaka, Japan
Site recruitment: Not reported
Research Site
Ōita, Japan
Site recruitment: Not reported
Research Site
Ōta-ku, Japan
Site recruitment: Not reported
Research Site
Shinjuku-ku, Japan
Site recruitment: Not reported
Research Site
Takatsuki, Japan
Site recruitment: Not reported
Research Site
Yokohama, Japan
Site recruitment: Not reported
Research Site
Bucheon-si, South Korea
Site recruitment: Not reported
Research Site
Daegu, South Korea
Site recruitment: Not reported
Research Site
Seoul, South Korea
Site recruitment: Not reported
Research Site
Changhua, Taiwan
Site recruitment: Not reported
Research Site
Chiayi City, Taiwan
Site recruitment: Not reported
Research Site
Kaohsiung City, Taiwan
Site recruitment: Not reported
Research Site
Tainan, Taiwan
Site recruitment: Not reported
Research Site
Taipei, Taiwan
Site recruitment: Not reported
Research Site
Taoyuan, Taiwan
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 3CompletedINTERVENTIONAL

Efficacy and Safety of Exenatide in Japanese Patients With Type 2 Diabetes Who Are Treated With Oral Antidiabetic(s)

ClinicalTrials.gov · NCT00577824 · Registry updated: 2015-04-09

Condition / research focus: Type 2 Diabetes
Sponsor: AstraZeneca
Countries with listed sites: Japan
Registry dates and results: Start: 2008-01. Completion: 2008-11 (may be estimated). Results are posted in this registry.

Products and interventions (3)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

exenatide (drug) — also listed as: LY2148568, Byetta
exenatide (drug) — also listed as: LY2148568, Byetta
placebo (drug)

Where the study takes place — 12 listed sites

Research Site
Chiba, Japan
Site recruitment: Not reported
Research Site
Fukuoka, Japan
Site recruitment: Not reported
Research Site
Fukushima, Japan
Site recruitment: Not reported
Research Site
Hyōgo, Japan
Site recruitment: Not reported
Research Site
Ibaraki, Japan
Site recruitment: Not reported
Research Site
Kanagawa, Japan
Site recruitment: Not reported
Research Site
Kumamoto, Japan
Site recruitment: Not reported
Research Site
Kyoto, Japan
Site recruitment: Not reported
Research Site
Nagano, Japan
Site recruitment: Not reported
Research Site
Osaka, Japan
Site recruitment: Not reported
Research Site
Ōita, Japan
Site recruitment: Not reported
Research Site
Tokyo, Japan
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 2CompletedINTERVENTIONAL

A Pilot Study of Effects of Exenatide on Body Weight in Non-Diabetic, Obese Patients

ClinicalTrials.gov · NCT00500370 · Registry updated: 2015-04-07

Condition / research focus: Obesity
Sponsor: AstraZeneca
Countries with listed sites: Puerto Rico · United States
Registry dates and results: Start: 2007-06. Completion: 2008-02 (may be estimated). Results are posted in this registry.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

exenatide (drug) — also listed as: Byetta
placebo (drug)

Where the study takes place — 16 listed sites

Research Site
Peoria, Arizona, United States
Site recruitment: Not reported
Research Site
Tucson, Arizona, United States
Site recruitment: Not reported
Research Site
Santa Ana, California, United States
Site recruitment: Not reported
Research Site
Indianapolis, Indiana, United States
Site recruitment: Not reported
Research Site
Topeka, Kansas, United States
Site recruitment: Not reported
Research Site
Wichita, Kansas, United States
Site recruitment: Not reported
Research Site
Baton Rouge, Louisiana, United States
Site recruitment: Not reported
Research Site
St Louis, Missouri, United States
Site recruitment: Not reported
Research Site
Oklahoma City, Oklahoma, United States
Site recruitment: Not reported
Research Site
Goose Creek, South Carolina, United States
Site recruitment: Not reported
Research Site
Spartanburg, South Carolina, United States
Site recruitment: Not reported
Research Site
Dallas, Texas, United States
Site recruitment: Not reported
Research Site
San Antonio, Texas, United States
Site recruitment: Not reported
Research Site
Renton, Washington, United States
Site recruitment: Not reported
Research Site
Ponce, Puerto Rico
Site recruitment: Not reported
Research Site
San Juan, Puerto Rico
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 3CompletedINTERVENTIONAL

Effects of Exenatide and Insulin Glargine in Subjects With Type 2 Diabetes

ClinicalTrials.gov · NCT00097500 · Registry updated: 2015-04-07

Condition / research focus: Type 2 Diabetes Mellitus
Sponsor: AstraZeneca
Countries with listed sites: Finland · Netherlands · Sweden
Registry dates and results: Start: 2004-09. Completion: 2009-12 (may be estimated). Results are posted in this registry.

Products and interventions (3)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

exenatide (drug) — also listed as: Byetta
Insulin glargine (drug) — also listed as: Lantus
Metformin (drug)

Where the study takes place — 3 listed sites

Research Site
Helsinki, Finland
Site recruitment: Not reported
Research Site
Amsterdam, Netherlands
Site recruitment: Not reported
Research Site
Gothenburg, Sweden
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 3CompletedINTERVENTIONAL

Safety and Efficacy of Exenatide in Patients With Type 2 Diabetes Using a Thiazolidinedione or a Thiazolidinedione and Metformin

ClinicalTrials.gov · NCT00603239 · Registry updated: 2015-04-07

Condition / research focus: Type 2 Diabetes Mellitus
Sponsor: AstraZeneca
Countries with listed sites: Canada · Mexico · Romania · South Africa · United States
Registry dates and results: Start: 2008-01. Completion: 2009-07 (may be estimated). Results are posted in this registry.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

exenatide (drug) — also listed as: Byetta
placebo (drug)

Where the study takes place — 25 listed sites

Research Site
Birmingham, Alabama, United States
Site recruitment: Not reported
Research Site
Concord, California, United States
Site recruitment: Not reported
Research Site
Fresno, California, United States
Site recruitment: Not reported
Research Site
Denver, Colorado, United States
Site recruitment: Not reported
Research Site
Las Vegas, Nevada, United States
Site recruitment: Not reported
Research Site
Mogadore, Ohio, United States
Site recruitment: Not reported
Research Site
Corvallis, Oregon, United States
Site recruitment: Not reported
Research Site
New Westminster, British Columbia, Canada
Site recruitment: Not reported
Research Site
Winnipeg, Manitoba, Canada
Site recruitment: Not reported
Research Site
Ajax, Ontario, Canada
Site recruitment: Not reported
Research Site
Cambridge, Ontario, Canada
Site recruitment: Not reported
Research Site
Windsor, Ontario, Canada
Site recruitment: Not reported
Research Site
Chihuahua City, Chihuahua, Mexico
Site recruitment: Not reported
Research Site
Celaya, Guanajuato, Mexico
Site recruitment: Not reported
Research Site
Mexico City, Mexico City, Mexico
Site recruitment: Not reported
Research Site
Monterrey, Nuevo León, Mexico
Site recruitment: Not reported
Research Site
Mexico City, Mexico
Site recruitment: Not reported
Research Site
Baia Mare, Romania
Site recruitment: Not reported
Research Site
Brasov, Romania
Site recruitment: Not reported
Research Site
Bucharest, Romania
Site recruitment: Not reported
Research Site
Dolj, Romania
Site recruitment: Not reported
Research Site
Iași, Romania
Site recruitment: Not reported
Research Site
Suceava, Romania
Site recruitment: Not reported
Research Site
Johannesburg, South Africa
Site recruitment: Not reported
Research Site
Pretoria, South Africa
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 3CompletedINTERVENTIONAL

An Exploratory Study of the Effect of Treatment Interruption on Safety of Exenatide in Patients With Type 2 Diabetes

ClinicalTrials.gov · NCT00516048 · Registry updated: 2015-04-07

Condition / research focus: Type 2 Diabetes Mellitus
Sponsor: AstraZeneca
Countries with listed sites: Australia · Canada · Hungary · Italy · South Korea
Registry dates and results: Start: 2007-08. Completion: 2008-04 (may be estimated). Results are posted in this registry.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

exenatide (drug) — also listed as: Byetta, AC2993, LY2148568

Where the study takes place — 13 listed sites

Research Site
Keswick, South Australia, Australia
Site recruitment: Not reported
Research Site
Calgary, Alberta, Canada
Site recruitment: Not reported
Research Site
Vancouver, British Columbia, Canada
Site recruitment: Not reported
Research Site
London, Ontario, Canada
Site recruitment: Not reported
Research Site
Budapest, Hungary
Site recruitment: Not reported
Research Site
Gyula, Hungary
Site recruitment: Not reported
Research Site
Zalaegerszeg, Hungary
Site recruitment: Not reported
Research Site
Milan, Italy
Site recruitment: Not reported
Research Site
Perugia, Italy
Site recruitment: Not reported
Research Site
Rome, Italy
Site recruitment: Not reported
Research Site
Seonnam City, South Korea
Site recruitment: Not reported
Research Site
Seoul, South Korea
Site recruitment: Not reported
Research Site
Suwon, South Korea
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 3CompletedINTERVENTIONAL

Effect of AC2993 Compared With Insulin Glargine in Patients With Type 2 Diabetes Also Using Combination Therapy With Sulfonylurea and Metformin

ClinicalTrials.gov · NCT00082381 · Registry updated: 2015-04-07

Condition / research focus: Diabetes Mellitus, Type 2
Sponsor: AstraZeneca
Countries with listed sites: Australia · Belgium · Brazil · Finland · Germany · Netherlands · Norway · Poland · Portugal · Puerto Rico · Spain · Sweden · United States
Registry dates and results: Start: 2003-06. Completion: 2008-07 (may be estimated). Results are posted in this registry.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Exenatide (AC2993) (drug) — also listed as: Byetta
Insulin glargine (drug) — also listed as: Lantus

Where the study takes place — 91 listed sites

Radiant Research-San Diego
San Diego, California, United States
Site recruitment: Not reported
Dorothy L. and James E. Frank Diabetes Research Institute
San Mateo, California, United States
Site recruitment: Not reported
Internal Medicine Associates Department of Research
Fort Myers, Florida, United States
Site recruitment: Not reported
Jacksonville Center for Clinical Research
Jacksonville, Florida, United States
Site recruitment: Not reported
Baptist Diabetes Associates
Miami, Florida, United States
Site recruitment: Not reported
Metabolic Research Institute, Inc.
West Palm Beach, Florida, United States
Site recruitment: Not reported
Springfield Diabetes & Endocrine Center
Springfield, Illinois, United States
Site recruitment: Not reported
Frederick Primary Care Associates
Frederick, Maryland, United States
Site recruitment: Not reported
Radiant Research, Inc.
St Louis, Missouri, United States
Site recruitment: Not reported
Lovelace Scientific Resources, Inc.
Las Vegas, Nevada, United States
Site recruitment: Not reported
Diabetes, Endocrine & Nutrition
Hampton, New Hampshire, United States
Site recruitment: Not reported
Lovelace Scientific Resources
Albuquerque, New Mexico, United States
Site recruitment: Not reported
Great Lakes Medical Research
Westfield, New York, United States
Site recruitment: Not reported
DOCS, Beth Israel Medical Center
Yonkers, New York, United States
Site recruitment: Not reported
Piedmont Medical Research Associates
Winston-Salem, North Carolina, United States
Site recruitment: Not reported
Jon Shapiro, MD
Philadelphia, Pennsylvania, United States
Site recruitment: Not reported
Endocrinology Consultants of East Tennessee
Knoxville, Tennessee, United States
Site recruitment: Not reported
Israel Hartman, MD
Arlington, Texas, United States
Site recruitment: Not reported
Diabetes & Glandular Research Associates, P.A.
San Antonio, Texas, United States
Site recruitment: Not reported
Jack Wahlen, MD
Ogden, Utah, United States
Site recruitment: Not reported
Rainier Clinical Research Center, Inc.
Renton, Washington, United States
Site recruitment: Not reported
Australian Clinical Research Centre
Miranda, New South Wales, Australia
Site recruitment: Not reported
Royal North Shore Hospital
St Leonards, New South Wales, Australia
Site recruitment: Not reported
Clinical Trial and Research Unit
Wollongong, New South Wales, Australia
Site recruitment: Not reported
Royal Brisbane Hospital
Brisbane, Queensland, Australia
Site recruitment: Not reported
Royal Adelaid Hospital
Adelaid, South Australia, Australia
Site recruitment: Not reported
Repatriation General Hospital
Daw Park, South Australia, Australia
Site recruitment: Not reported
SA Endocrine Clinical Research
Keswick, South Australia, Australia
Site recruitment: Not reported
Eastern Health (Box Hill Hospital)
Box Hill, Victoria, Australia
Site recruitment: Not reported
Royal Melbourne Hospital
Parkville, Victoria, Australia
Site recruitment: Not reported
Freemantle Hospital
Freemantle, Western Australia, Australia
Site recruitment: Not reported
UZ Antwerpen
Endegem, Belgium
Site recruitment: Not reported
UZ Gent
Ghent, Belgium
Site recruitment: Not reported
UZ Gasthuisberg
Leuven, Belgium
Site recruitment: Not reported
CHU Sart Tilman
Liège, Belgium
Site recruitment: Not reported
A.Z. Jan Palfijn
Merksem, Belgium
Site recruitment: Not reported
Sint Niklaasstraat
Sint-Gillis-Waas, Belgium
Site recruitment: Not reported
Hospital Nossa Senhora das Gracas
Curitiba, Brazil
Site recruitment: Not reported
Centro Integrado de Diabetes e Hipertensao
Fortaleza, Brazil
Site recruitment: Not reported
Centro de Pesquisas em Diabetes e Doencas Endocrino Metabolicas/HUWC/UFC
Fortaleza, Brazil
Site recruitment: Not reported
Santa Casa de Misericordia de Porto Alegre
Porto Alegre, Brazil
Site recruitment: Not reported
Eiran Sairaala c/o9 Clires
Helsinki, Finland
Site recruitment: Not reported
Torikeskuksen Laakariasema, Yliopistonkatu
Jyväskylä, Finland
Site recruitment: Not reported
Oulu Deakoness Institution
Oulu, Finland
Site recruitment: Not reported
Diabetologische Schwerpunktpraxis
Aschaffenburg, Germany
Site recruitment: Not reported
Diabetologische Scherpunktpraxis
Bosenheim, Germany
Site recruitment: Not reported
Diabetologische Schwerpunktpraxis
Dortmund, Germany
Site recruitment: Not reported
Krankenhaus Bethanien
Hamburg, Germany
Site recruitment: Not reported
Universitatskliniken des Saarlandes
Homburg/Saar, Germany
Site recruitment: Not reported
IKFE GmbH
Mainz, Germany
Site recruitment: Not reported
Profil Institut fur Stoffwechselforschung GmbH
Neuss, Germany
Site recruitment: Not reported
Diabetologische Schwerpunktpraxis
Neuwied, Germany
Site recruitment: Not reported
Diabetes Centrum Bilthoven
Bilthoven, Netherlands
Site recruitment: Not reported
Atrium Medisch Centrum Brunssum
Brunssum, Netherlands
Site recruitment: Not reported
Sint Antonius Ziekenhuis Nieuwegein
Nieuwegein, Netherlands
Site recruitment: Not reported
Refaja ziekenhuis
Stadskanaal, Netherlands
Site recruitment: Not reported
Medisch Centrum
Westeinde, Netherlands
Site recruitment: Not reported
Markeveien Spesialistpraksis
Bergen, Norway
Site recruitment: Not reported
Spesiallegetjenesten AS
Jessheim, Norway
Site recruitment: Not reported
Betanien Spesialistsenter
Oslo, Norway
Site recruitment: Not reported
Sykehuset Asker of Baerum HF
Rud, Norway
Site recruitment: Not reported
Forskningsstiftelsen Hjertelaget
Stravanger, Norway
Site recruitment: Not reported
Bydgoskie Centrum Diabetologii i Endokrynologii
Bydgoszcz, Poland
Site recruitment: Not reported
Oddzial Chorob Wewnetrznych
Częstochowa, Poland
Site recruitment: Not reported
NZOZ "Diab-Endo-Met"
Krakow, Poland
Site recruitment: Not reported
Poradnia Diabetologiczna
Lodz, Poland
Site recruitment: Not reported
Poradnia Diabetologiczna
Lublin, Poland
Site recruitment: Not reported
Oddzial Chorob Wewnetrznych
Mielec, Poland
Site recruitment: Not reported
Oddzial Chorob Wewnetrznych i Diabetologii
Warsaw, Poland
Site recruitment: Not reported
Wojewodzka Poradnia dla Chorych na Cukrzyce
Warsaw, Poland
Site recruitment: Not reported
Hospital Garcia de Orta-Servico de Endocrinologia
Almada, Portugal
Site recruitment: Not reported
Centro Hospitalar de Coimbra
Coimbra, Portugal
Site recruitment: Not reported
Associacao Protectora dos Diabeticos de Portugal
Lisbon, Portugal
Site recruitment: Not reported
Hospital Geral de Santo Antonio
Porto, Portugal
Site recruitment: Not reported
Universidad Central del Caribe
Bayamón, Puerto Rico
Site recruitment: Not reported
Hospital Alejandro Otero Lopez
Manati, Puerto Rico
Site recruitment: Not reported
Dr. Luis Ruiz
Ponce, Puerto Rico
Site recruitment: Not reported
RCMI-Clinical Research Center
Rio Piedras, Puerto Rico
Site recruitment: Not reported
San Juan Health Center
San Juan, Puerto Rico
Site recruitment: Not reported
Centro de Endocrinologia del Este
Yabucoa, Puerto Rico
Site recruitment: Not reported
Hospital Vega Baja
Alicante, Spain
Site recruitment: Not reported
Hospital Doce de Octubre
Madrid, Spain
Site recruitment: Not reported
Hospital Gral de Mostoles
Madrid, Spain
Site recruitment: Not reported
Hospital Virgen de Valme
Seville, Spain
Site recruitment: Not reported
Hospital la Ribera, Alzira
Valencia, Spain
Site recruitment: Not reported
Lundberglaboratoriet for diabetesforskning
Gothenburg, Sweden
Site recruitment: Not reported
Medicinska kliniken
Helsingborg, Sweden
Site recruitment: Not reported
Kliniska Forskningsenheren
Lund, Sweden
Site recruitment: Not reported
Diabetesmottagningen, Intermedicinska kliniken
Stockholm, Sweden
Site recruitment: Not reported
CME, M71
Stockholm, Sweden
Site recruitment: Not reported
Enheten for metabol kontroll
Stockholm, Sweden
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 3CompletedINTERVENTIONAL

A Trial Comparing Two Therapies: Basal Insulin/Glargine, Exenatide and Metformin Therapy (BET) or Basal Insulin/Glargine, Bolus Insulin Lispro and Metformin Therapy (BBT) in Subjects With Type 2 Diabetes

ClinicalTrials.gov · NCT00960661 · Registry updated: 2015-04-07

Condition / research focus: Type 2 Diabetes Mellitus
Sponsor: AstraZeneca
Countries with listed sites: Argentina · Belgium · Estonia · Finland · France · Germany · Greece · Italy · Mexico · Netherlands · Portugal · Puerto Rico · Romania · Russia · South Korea · Spain · Sweden · United Kingdom
Registry dates and results: Start: 2009-09. Completion: 2012-08 (may be estimated). Results are posted in this registry.

Products and interventions (4)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

exenatide (drug) — also listed as: Byetta
insulin lispro (drug) — also listed as: Humalog
Metformin (drug)
Insulin/ Glargine (drug)

Where the study takes place — 95 listed sites

Research Site
Buenos Aires, Argentina
Site recruitment: Not reported
Research Site
Caba, Argentina
Site recruitment: Not reported
Research Site
Capital Federal, Argentina
Site recruitment: Not reported
Research Site
Ciudad Autonoma de Buenos Aire, Argentina
Site recruitment: Not reported
Research Site
Ciudad de Buenos Aires, Argentina
Site recruitment: Not reported
Research Site
Corrientes, Argentina
Site recruitment: Not reported
Research Site
Rosario, Argentina
Site recruitment: Not reported
Research Site
San Rafael, Argentina
Site recruitment: Not reported
Research Site
Arlon, Belgium
Site recruitment: Not reported
Research Site
Bonheiden, Belgium
Site recruitment: Not reported
Research Site
Edegem, Belgium
Site recruitment: Not reported
Research Site
Merksem, Belgium
Site recruitment: Not reported
Research Site
Tallinn, Estonia
Site recruitment: Not reported
Research Site
Tartu, Estonia
Site recruitment: Not reported
Research Site
Helsinki, Finland
Site recruitment: Not reported
Research Site
Oulu, Finland
Site recruitment: Not reported
Research Site
Vantaa, Finland
Site recruitment: Not reported
Research Site
Angers, France
Site recruitment: Not reported
Research Site
Auxerre, France
Site recruitment: Not reported
Research Site
Bar-le-Duc, France
Site recruitment: Not reported
Research Site
Douai, France
Site recruitment: Not reported
Research Site
La Roche-sur-Yon, France
Site recruitment: Not reported
Research Site
La Rochelle, France
Site recruitment: Not reported
Research Site
Le Creuzot, France
Site recruitment: Not reported
Research Site
Lille, France
Site recruitment: Not reported
Research Site
Marseille, France
Site recruitment: Not reported
Research Site
Montpellier, France
Site recruitment: Not reported
Research Site
Nanterre, France
Site recruitment: Not reported
Research Site
Pessac, France
Site recruitment: Not reported
Research Site
Rennes, France
Site recruitment: Not reported
Research Site
Strasbourg, France
Site recruitment: Not reported
Research Site
Toulouse, France
Site recruitment: Not reported
Research Site
Vénissieux, France
Site recruitment: Not reported
Research Site
Bad Lauterberg im Harz, Germany
Site recruitment: Not reported
Research Site
Dippoldiswalde, Germany
Site recruitment: Not reported
Research Site
Friedrichsthal, Germany
Site recruitment: Not reported
Research Site
Goch, Germany
Site recruitment: Not reported
Research Site
Grevenbroich, Germany
Site recruitment: Not reported
Research Site
Hamburg, Germany
Site recruitment: Not reported
Research Site
Mainz, Germany
Site recruitment: Not reported
Research Site
Saarbrücken, Germany
Site recruitment: Not reported
Research Site
Athens, Greece
Site recruitment: Not reported
Research Site
Thessaloniki, Greece
Site recruitment: Not reported
Research Site
Florence, Italy
Site recruitment: Not reported
Research Site
Naples, Italy
Site recruitment: Not reported
Research Site
Olbia, Italy
Site recruitment: Not reported
Research Site
Perugia, Italy
Site recruitment: Not reported
Research Site
Trieste, Italy
Site recruitment: Not reported
Research Site
Verona, Italy
Site recruitment: Not reported
Research Site
Aguascalientes, Mexico
Site recruitment: Not reported
Research Site
Cuernavaca, Mexico
Site recruitment: Not reported
Research Site
Mexico City, Mexico
Site recruitment: Not reported
Research Site
Monterrey, Mexico
Site recruitment: Not reported
Research Site
Almere Stad, Netherlands
Site recruitment: Not reported
Research Site
Amsterdam, Netherlands
Site recruitment: Not reported
Research Site
Beek, Netherlands
Site recruitment: Not reported
Research Site
Groningen, Netherlands
Site recruitment: Not reported
Research Site
Heerlen, Netherlands
Site recruitment: Not reported
Research Site
Hoogeveen, Netherlands
Site recruitment: Not reported
Research Site
Sittard-Geleen, Netherlands
Site recruitment: Not reported
Research Site
The Hague, Netherlands
Site recruitment: Not reported
Research Site
Coimbra, Portugal
Site recruitment: Not reported
Research Site
Lisbon, Portugal
Site recruitment: Not reported
Research Site
Portugal, Portugal
Site recruitment: Not reported
Research Site
Hato Rey, Puerto Rico
Site recruitment: Not reported
Research Site
Bucharest, Romania
Site recruitment: Not reported
Research Site
Cluj-Napoca, Romania
Site recruitment: Not reported
Research Site
Constanța, Romania
Site recruitment: Not reported
Research Site
Craiova, Romania
Site recruitment: Not reported
Research Site
Oradea, Romania
Site recruitment: Not reported
Research Site
Ploieşti, Romania
Site recruitment: Not reported
Research Site
Arkhangelsk, Russia
Site recruitment: Not reported
Research Site
Rostov-on-Don, Russia
Site recruitment: Not reported
Research Site
Saint Petersburg, Russia
Site recruitment: Not reported
Research Site
Seoul, South Korea
Site recruitment: Not reported
Research Site
Ulsan, South Korea
Site recruitment: Not reported
Research Site
Wŏnju, South Korea
Site recruitment: Not reported
Research Site
A Coruña, Spain
Site recruitment: Not reported
Research Site
Alicante, Spain
Site recruitment: Not reported
Research Site
Barcelona, Spain
Site recruitment: Not reported
Research Site
Dos Hermanas, Spain
Site recruitment: Not reported
Research Site
Santander, Spain
Site recruitment: Not reported
Research Site
Valencia, Spain
Site recruitment: Not reported
Research Site
Halmstad, Sweden
Site recruitment: Not reported
Research Site
Karlstad, Sweden
Site recruitment: Not reported
Research Site
Lund, Sweden
Site recruitment: Not reported
Research Site
Malmö, Sweden
Site recruitment: Not reported
Research Site
Solna, Sweden
Site recruitment: Not reported
Research Site
Stockholm, Sweden
Site recruitment: Not reported
Research Site
Umeå, Sweden
Site recruitment: Not reported
Research Site
Bournemouth, United Kingdom
Site recruitment: Not reported
Research Site
Ipswich, United Kingdom
Site recruitment: Not reported
Research Site
Leicester, United Kingdom
Site recruitment: Not reported
Research Site
Penarth, United Kingdom
Site recruitment: Not reported
Research Site
Wakefield, United Kingdom
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 3CompletedINTERVENTIONAL

Effect of Exenatide Plus Metformin vs. Insulin Aspart Plus Metformin on Glycemic Control and Hypoglycemia in Patients With Type 2 Diabetes

ClinicalTrials.gov · NCT00434954 · Registry updated: 2015-04-07

Condition / research focus: Type 2 Diabetes Mellitus
Sponsor: AstraZeneca
Countries with listed sites: Germany
Registry dates and results: Start: 2007-02. Completion: 2009-06 (may be estimated). Results are posted in this registry.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

exenatide twice daily (BID) (drug) — also listed as: Byetta
premixed insulin aspart twice daily (BID) (drug)

Where the study takes place — 39 listed sites

Research Site
Bad Mergentheim, Germany
Site recruitment: Not reported
Research Site
Berlin, Germany
Site recruitment: Not reported
Research Site
Bosenheim, Germany
Site recruitment: Not reported
Research Site
Burghausen, Germany
Site recruitment: Not reported
Research Site
Datteln, Germany
Site recruitment: Not reported
Research Site
Dresden, Germany
Site recruitment: Not reported
Research Site
Essen, Germany
Site recruitment: Not reported
Research Site
Friedrichsthal, Germany
Site recruitment: Not reported
Research Site
Hildesheim, Germany
Site recruitment: Not reported
Research Site
Hirschhorn, Germany
Site recruitment: Not reported
Research Site
Hohenmölsen, Germany
Site recruitment: Not reported
Research Site
Jena, Germany
Site recruitment: Not reported
Research Site
Lehrte, Germany
Site recruitment: Not reported
Research Site
Leipzig, Germany
Site recruitment: Not reported
Research Site
Ludwigsburg, Germany
Site recruitment: Not reported
Research Site
Mannheim, Germany
Site recruitment: Not reported
Research Site
Marburg, Germany
Site recruitment: Not reported
Research Site
Marktheidenfeld, Germany
Site recruitment: Not reported
Research Site
Meissen, Germany
Site recruitment: Not reported
Research Site
München, Germany
Site recruitment: Not reported
Research Site
Offenbach, Germany
Site recruitment: Not reported
Research Site
Oschatz, Germany
Site recruitment: Not reported
Research Site
Pohlheim, Germany
Site recruitment: Not reported
Research Site
Regensburg, Germany
Site recruitment: Not reported
Research Site
Riesa, Germany
Site recruitment: Not reported
Research Site
Rodgau, Germany
Site recruitment: Not reported
Research Site
Roding, Germany
Site recruitment: Not reported
Research Site
Rosenheim, Germany
Site recruitment: Not reported
Research Site
Schlüchtern, Germany
Site recruitment: Not reported
Research Site
Schwedt, Germany
Site recruitment: Not reported
Research Site
Sinsheim, Germany
Site recruitment: Not reported
Research Site
Speyer, Germany
Site recruitment: Not reported
Research Site
Unterhaching, Germany
Site recruitment: Not reported
Research Site
Völklingen, Germany
Site recruitment: Not reported
Research Site
Wallerfing, Germany
Site recruitment: Not reported
Research Site
Wangen, Germany
Site recruitment: Not reported
Research Site
Warburg, Germany
Site recruitment: Not reported
Research Site
Wiesbaden, Germany
Site recruitment: Not reported
Research Site
Wolfsburg, Germany
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 3CompletedINTERVENTIONAL

Effect on Weight Loss of Exenatide Versus Placebo

ClinicalTrials.gov · NCT00375492 · Registry updated: 2015-04-07

Condition / research focus: Type 2 Diabetes Mellitus
Sponsor: AstraZeneca
Countries with listed sites: United States
Registry dates and results: Start: 2006-09. Completion: 2008-02 (may be estimated). Results are posted in this registry.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

exenatide (drug) — also listed as: Byetta
placebo (drug)

Where the study takes place — 10 listed sites

Research Site
Peoria, Arizona, United States
Site recruitment: Not reported
Research Site
Jacksonville, Florida, United States
Site recruitment: Not reported
Research Site
Orlando, Florida, United States
Site recruitment: Not reported
Research Site
Indianapolis, Indiana, United States
Site recruitment: Not reported
Research Site
Boston, Massachusetts, United States
Site recruitment: Not reported
Research Site
Minneapolis, Minnesota, United States
Site recruitment: Not reported
Research Site
St Louis, Missouri, United States
Site recruitment: Not reported
Research Site
Spartanburg, South Carolina, United States
Site recruitment: Not reported
Research Site
San Antonio, Texas, United States
Site recruitment: Not reported
Research Site
Renton, Washington, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 3CompletedINTERVENTIONAL

A Study to Compare the Glycemic Effects, Safety, and Tolerability of Exenatide Once Weekly to Those of Sitagliptin and Pioglitazone,in Subjects With Type 2 Diabetes Treated With Metformin (DURATION - 2)

ClinicalTrials.gov · NCT00637273 · Registry updated: 2015-04-07

Condition / research focus: Type 2 Diabetes Mellitus
Sponsor: AstraZeneca
Countries with listed sites: India · Mexico · United States
Registry dates and results: Start: 2008-01. Completion: 2009-07 (may be estimated). Results are posted in this registry.

Products and interventions (5)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

exenatide once weekly (drug)
sitagliptin (drug) — also listed as: Januvia
pioglitazone (drug)
placebo tablet (drug)
placebo once weekly (drug)

Where the study takes place — 62 listed sites

Research Site
Peoria, Arizona, United States
Site recruitment: Not reported
Research Site
Artesia, California, United States
Site recruitment: Not reported
Research Site
Concord, California, United States
Site recruitment: Not reported
Research Site
Encino, California, United States
Site recruitment: Not reported
Research Site
Greenbrae, California, United States
Site recruitment: Not reported
Research Site
La Mesa, California, United States
Site recruitment: Not reported
Research Site
Orange, California, United States
Site recruitment: Not reported
Research Site
Walnut Creek, California, United States
Site recruitment: Not reported
Research Site
Whittier, California, United States
Site recruitment: Not reported
Research Site
Colorado Springs, Colorado, United States
Site recruitment: Not reported
Research Site
Washington D.C., District of Columbia, United States
Site recruitment: Not reported
Research Site
Coral Gables, Florida, United States
Site recruitment: Not reported
Research Site
DeLand, Florida, United States
Site recruitment: Not reported
Research Site
Melbourne, Florida, United States
Site recruitment: Not reported
Research Site
Miami, Florida, United States
Site recruitment: Not reported
Research Site
New Port Richey, Florida, United States
Site recruitment: Not reported
Research Site
Decatur, Georgia, United States
Site recruitment: Not reported
Research Site
Avon, Indiana, United States
Site recruitment: Not reported
Research Site
Wichita, Kansas, United States
Site recruitment: Not reported
Research Site
Paducah, Kentucky, United States
Site recruitment: Not reported
Research Site
Baton Rouge, Louisiana, United States
Site recruitment: Not reported
Research Site
New Orleans, Louisiana, United States
Site recruitment: Not reported
Research Site
Oxon Hill, Maryland, United States
Site recruitment: Not reported
Research Site
Boston, Massachusetts, United States
Site recruitment: Not reported
Research Site
Chelsea, Michigan, United States
Site recruitment: Not reported
Research Site
Ypsilanti, Michigan, United States
Site recruitment: Not reported
Research Site
Saint Louis Park, Minnesota, United States
Site recruitment: Not reported
Research Site
St Louis, Missouri, United States
Site recruitment: Not reported
Research Site
Butte, Montana, United States
Site recruitment: Not reported
Research Site
Lincoln, Nebraska, United States
Site recruitment: Not reported
Research Site
Las Vegas, Nevada, United States
Site recruitment: Not reported
Research Site
New Hyde Park, New York, United States
Site recruitment: Not reported
Research Site
New Windsor, New York, United States
Site recruitment: Not reported
Research Site
New York, New York, United States
Site recruitment: Not reported
Research Site
Rochester, New York, United States
Site recruitment: Not reported
Research Site
Durham, North Carolina, United States
Site recruitment: Not reported
Research Site
Statesville, North Carolina, United States
Site recruitment: Not reported
Research Site
Winston-Salem, North Carolina, United States
Site recruitment: Not reported
Research Site
Athens, Ohio, United States
Site recruitment: Not reported
Research Site
Cincinnati, Ohio, United States
Site recruitment: Not reported
Research Site
Dayton, Ohio, United States
Site recruitment: Not reported
Research Site
Philadelphia, Pennsylvania, United States
Site recruitment: Not reported
Research Site
Rapid City, South Dakota, United States
Site recruitment: Not reported
Research Site
Memphis, Tennessee, United States
Site recruitment: Not reported
Research Site
Austin, Texas, United States
Site recruitment: Not reported
Research Site
Dallas, Texas, United States
Site recruitment: Not reported
Research Site
San Antonio, Texas, United States
Site recruitment: Not reported
Research Site
Richmond, Virginia, United States
Site recruitment: Not reported
Research Site
Olympia, Washington, United States
Site recruitment: Not reported
Research Site
Spokane, Washington, United States
Site recruitment: Not reported
Research Site
Tacoma, Washington, United States
Site recruitment: Not reported
Research Site
Bangalore, India
Site recruitment: Not reported
Research Site
Indore, India
Site recruitment: Not reported
Research Site
Karnāl, India
Site recruitment: Not reported
Research Site
Mumbai, India
Site recruitment: Not reported
Research Site
Pune, India
Site recruitment: Not reported
Research Site
Guadalajara, Jalisco, Mexico
Site recruitment: Not reported
Research Site
Zapopan, Jalisco, Mexico
Site recruitment: Not reported
Research Site
Mexico City, Mexico City, Mexico
Site recruitment: Not reported
Research Site
Cuernavaca, Morelos, Mexico
Site recruitment: Not reported
Research Site
Monterrey, NuevoLeon, Mexico
Site recruitment: Not reported
Research Site
Toluca, State of Mexico, Mexico
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 3CompletedINTERVENTIONAL

Exenatide Compared With Twice-Daily Biphasic Insulin Aspart in Patients With Type 2 Diabetes Using Sulfonylurea and Metformin

ClinicalTrials.gov · NCT00082407 · Registry updated: 2015-04-07

Condition / research focus: Diabetes Mellitus, Type 2
Sponsor: AstraZeneca
Countries with listed sites: Croatia · Germany · Greece · Italy · Netherlands · Portugal · Romania · Russia · Slovenia · Spain · Taiwan · United Kingdom
Registry dates and results: Start: 2003-11. Completion: 2008-07 (may be estimated). Results are posted in this registry.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

exenatide (drug) — also listed as: Byetta
biphasic insulin aspart (drug) — also listed as: NovoLog

Where the study takes place — 69 listed sites

Clinical Hospital Osijek
Osijek, Croatia
Site recruitment: Not reported
Klinica bolnica Dubrava
Zagreb, Croatia
Site recruitment: Not reported
Klinicki bolnicki centar Zagreb-Rebro
Zagreb, Croatia
Site recruitment: Not reported
Opca bolnica "Sveti Duh"
Zagreb, Croatia
Site recruitment: Not reported
Internistische Gemeinschaftspraxis
Augsburg, Germany
Site recruitment: Not reported
Dr. Karlheinz Hehemann
Beckum, Germany
Site recruitment: Not reported
Dr. Klaus Busch
Dortmund, Germany
Site recruitment: Not reported
Medical Clinic and Policlinic 3
Giessen, Germany
Site recruitment: Not reported
Diabetologische Schwerpunktpraxis
Hamburg, Germany
Site recruitment: Not reported
IKFE GmbH
Mainz, Germany
Site recruitment: Not reported
Institut for diabetic research
Munich, Germany
Site recruitment: Not reported
Profil, Institut fur Stoffwechselstorungen
Neuss, Germany
Site recruitment: Not reported
Dr. Thomas Behnke
Neuwied, Germany
Site recruitment: Not reported
Dr. Bernd Donaubauer
Oschatz, Germany
Site recruitment: Not reported
Marienhospital Osnabruck
Osnabrück, Germany
Site recruitment: Not reported
Dr. Joerg Steindorf
Schkeuditz, Germany
Site recruitment: Not reported
Dr. Jerzi Jasinski
Wiesbaden, Germany
Site recruitment: Not reported
"Polyclinic" General Hospital of Athens
Athens, Greece
Site recruitment: Not reported
Department of Endocrinology
Athens, Greece
Site recruitment: Not reported
Diabetes Center
Athens, Greece
Site recruitment: Not reported
University Hospital of Patras
Pátrai, Greece
Site recruitment: Not reported
1st Internal Medicine Department "Papagergiou"
Thessaloniki, Greece
Site recruitment: Not reported
Instituto di Endocrinologia
Catania, Italy
Site recruitment: Not reported
Dipartimento di fisiopatologia clinica
Florence, Italy
Site recruitment: Not reported
U.O. Medicina Generale
Milan, Italy
Site recruitment: Not reported
Ospedale Civile di Padova
Padova, Italy
Site recruitment: Not reported
Policlinico Univarsitario P. Giaccone
Palermo, Italy
Site recruitment: Not reported
U.O. Universita di Malattie del Metabolismo e Diabetologia
Torino, Italy
Site recruitment: Not reported
Gelre Ziekenhuizen
Apeldoorn, Netherlands
Site recruitment: Not reported
Rijnstate Ziekenhuis
Arnhem, Netherlands
Site recruitment: Not reported
Maxima Medisch Centrum Location Eindhoven
Eindhoven, Netherlands
Site recruitment: Not reported
Hospitais da Universidade de Coimbra
Coimbra, Portugal
Site recruitment: Not reported
Hospital de Santo Andre
Leiria, Portugal
Site recruitment: Not reported
Associacao Protectora dos Diabeticos de Portugal
Lisbon, Portugal
Site recruitment: Not reported
Hospital Pedro Hispano
Matosinhos Municipality, Portugal
Site recruitment: Not reported
Spitalul Judetean Brasov
Brasov, Romania
Site recruitment: Not reported
Institutul de Diabet
Bucharest, Romania
Site recruitment: Not reported
Spitalul Clinic nr. 1 Judetean
Judet Timis, Romania
Site recruitment: Not reported
National Endocrinology Research Center
Moscow, Russia
Site recruitment: Not reported
Setchenov Moscow Medical Academy
Moscow, Russia
Site recruitment: Not reported
Moscow State Medical Stomatological
Moscow, Russia
Site recruitment: Not reported
Russian Medical Academy for Advanced Medical Studies, Ministry of Health
Moscow, Russia
Site recruitment: Not reported
Hospital of St. Elizabeth's
Saint Petersburg, Russia
Site recruitment: Not reported
City Clinical Hospital #2
Saint Petersburg, Russia
Site recruitment: Not reported
Medical Military Academy
Saint Petersburg, Russia
Site recruitment: Not reported
Univerzitetni klinicni center Ljubljana
Ljubljana, Slovenia
Site recruitment: Not reported
Splosna bolnisnica Maribor
Maribor, Slovenia
Site recruitment: Not reported
Hospital Vega Baja
Alicante, Spain
Site recruitment: Not reported
Hospital Clinic i Provincial de Barcelona
Barcelona, Spain
Site recruitment: Not reported
Endocrinology Service (Planta Baja)
Palma de Mallorca, Spain
Site recruitment: Not reported
Hospital Virgen de Valme
Seville, Spain
Site recruitment: Not reported
Hospital General de Teruel
Teruel, Spain
Site recruitment: Not reported
Hospital la Ribera Alzira
Valencia, Spain
Site recruitment: Not reported
Changhua Christian Hospital
Changhua, Taiwan
Site recruitment: Not reported
Tzu Chi General Hospital
Hualien City, Taiwan
Site recruitment: Not reported
Veteran General Hospital-Taichung
Taichung, Taiwan
Site recruitment: Not reported
Tri-Service General Hospital
Taipei, Taiwan
Site recruitment: Not reported
Diabetes Research, Ward 34, Birmingham Heartlands Hospital
Birmingham, United Kingdom
Site recruitment: Not reported
Diabetes Unit, Blackburn Royal Infirmary
Blackburn, United Kingdom
Site recruitment: Not reported
Colchester General Hospital
Colchester, United Kingdom
Site recruitment: Not reported
Royal Infirmary of Edinburgh
Edinburgh, United Kingdom
Site recruitment: Not reported
Glasgow Royal Infirmary
Glasgow, United Kingdom
Site recruitment: Not reported
The Michael White Center for Diabetes and Endocrinology
Hull, United Kingdom
Site recruitment: Not reported
Clinical Sciences Centre
Liverpool, United Kingdom
Site recruitment: Not reported
Education Centre, James Cook University Hospital
Middlesbrough, United Kingdom
Site recruitment: Not reported
Wellcome Labs, Royal Victoria Infirmary
Newcastle upon Tyne, United Kingdom
Site recruitment: Not reported
Queens Medical Centre
Nottingham, United Kingdom
Site recruitment: Not reported
Diabetes Trial Unit OCDEM, Churchill Hospital
Oxford, United Kingdom
Site recruitment: Not reported
Diabetes Unit, Gladsone Centre, Maelor Hospital
Wrexham, United Kingdom
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 3CompletedINTERVENTIONAL

A Study to Evaluate the Glycemic Effects, Safety, and Tolerability of Exenatide Once Weekly in Subjects With Type 2 Diabetes Mellitus (DURATION-5)

ClinicalTrials.gov · NCT00877890 · Registry updated: 2015-04-07

Condition / research focus: Type 2 Diabetes Mellitus
Sponsor: AstraZeneca
Countries with listed sites: United States
Registry dates and results: Start: 2009-03. Completion: 2010-01 (may be estimated). Results are posted in this registry.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

exenatide once weekly (drug) — also listed as: BYDUREON
exenatide twice daily (drug) — also listed as: BYETTA

Where the study takes place — 41 listed sites

Research Site
Birmingham, Alabama, United States
Site recruitment: Not reported
Research Site
Mesa, Arizona, United States
Site recruitment: Not reported
Research Site
Peoria, Arizona, United States
Site recruitment: Not reported
Research Site
Artesia, California, United States
Site recruitment: Not reported
Research Site
Concord, California, United States
Site recruitment: Not reported
Research Site
Encino, California, United States
Site recruitment: Not reported
Research Site
Greenbrae, California, United States
Site recruitment: Not reported
Research Site
La Mesa, California, United States
Site recruitment: Not reported
Research Site
Walnut Creek, California, United States
Site recruitment: Not reported
Research Site
DeLand, Florida, United States
Site recruitment: Not reported
Research Site
Hialeah, Florida, United States
Site recruitment: Not reported
Research Site
Miami, Florida, United States
Site recruitment: Not reported
Research Site
New Port Richey, Florida, United States
Site recruitment: Not reported
Research Site
Palm Harbor, Florida, United States
Site recruitment: Not reported
Research Site
Chicago, Illinois, United States
Site recruitment: Not reported
Research Site
Avon, Indiana, United States
Site recruitment: Not reported
Research Site
Evansville, Indiana, United States
Site recruitment: Not reported
Research Site
Lexington, Kentucky, United States
Site recruitment: Not reported
Research Site
Paducah, Kentucky, United States
Site recruitment: Not reported
Research Site
Detroit, Michigan, United States
Site recruitment: Not reported
Research Site
Edina, Minnesota, United States
Site recruitment: Not reported
Research Site
St Louis, Missouri, United States
Site recruitment: Not reported
Research Site
Butte, Montana, United States
Site recruitment: Not reported
Research Site
New Hyde Park, New York, United States
Site recruitment: Not reported
Research Site
Rochester, New York, United States
Site recruitment: Not reported
Research Site
Raleigh, North Carolina, United States
Site recruitment: Not reported
Research Site
Statesville, North Carolina, United States
Site recruitment: Not reported
Research Site
Cincinnati, Ohio, United States
Site recruitment: Not reported
Research Site
Delaware, Ohio, United States
Site recruitment: Not reported
Research Site
Mentor, Ohio, United States
Site recruitment: Not reported
Research Site
Eugene, Oregon, United States
Site recruitment: Not reported
Research Site
Rapid City, South Dakota, United States
Site recruitment: Not reported
Research Site
Austin, Texas, United States
Site recruitment: Not reported
Research Site
Corpus Christi, Texas, United States
Site recruitment: Not reported
Research Site
San Antonio, Texas, United States
Site recruitment: Not reported
Research Site
Burke, Virginia, United States
Site recruitment: Not reported
Research Site
Manassas, Virginia, United States
Site recruitment: Not reported
Research Site
Richmond, Virginia, United States
Site recruitment: Not reported
Research Site
Olympia, Washington, United States
Site recruitment: Not reported
Research Site
Spokane, Washington, United States
Site recruitment: Not reported
Research Site
Tacoma, Washington, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 3CompletedINTERVENTIONAL

Efficacy of Once-Weekly Exenatide Versus Once or Twice Daily Insulin Detemir in Patients With Type 2 Diabetes

ClinicalTrials.gov · NCT01003184 · Registry updated: 2015-04-07

Condition / research focus: Type 2 Diabetes Mellitus
Sponsor: AstraZeneca
Countries with listed sites: Ireland · United Kingdom
Registry dates and results: Start: 2009-10. Completion: 2011-12 (may be estimated). Results are posted in this registry.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

exenatide once weekly (drug)
insulin detemir (drug) — also listed as: Levemir

Where the study takes place — 34 listed sites

Research Site
Dublin, Ireland
Site recruitment: Not reported
Research Site
Addlestone, England, United Kingdom
Site recruitment: Not reported
Research Site
Bath, England, United Kingdom
Site recruitment: Not reported
Research Site
Birmingham, England, United Kingdom
Site recruitment: Not reported
Research Site
Blackburn, England, United Kingdom
Site recruitment: Not reported
Research Site
Bournemouth, England, United Kingdom
Site recruitment: Not reported
Research Site
Chippenham, England, United Kingdom
Site recruitment: Not reported
Research Site
Derby, England, United Kingdom
Site recruitment: Not reported
Research Site
Exeter, England, United Kingdom
Site recruitment: Not reported
Research Site
High Wycombe, England, United Kingdom
Site recruitment: Not reported
Research Site
Hull, England, United Kingdom
Site recruitment: Not reported
Research Site
Leicester, England, United Kingdom
Site recruitment: Not reported
Research Site
Liverpool, England, United Kingdom
Site recruitment: Not reported
Research Site
London, England, United Kingdom
Site recruitment: Not reported
Research Site
Manchester, England, United Kingdom
Site recruitment: Not reported
Research Site
Merseyside, England, United Kingdom
Site recruitment: Not reported
Research Site
Middlesbrough, England, United Kingdom
Site recruitment: Not reported
Research Site
Newcastle, England, United Kingdom
Site recruitment: Not reported
Research Site
Northampton, England, United Kingdom
Site recruitment: Not reported
Research Site
Oldham, England, United Kingdom
Site recruitment: Not reported
Research Site
Plymouth, England, United Kingdom
Site recruitment: Not reported
Research Site
Portsmouth, England, United Kingdom
Site recruitment: Not reported
Research Site
Sheffield, England, United Kingdom
Site recruitment: Not reported
Research Site
Stevenage, England, United Kingdom
Site recruitment: Not reported
Research Site
Suffolk, England, United Kingdom
Site recruitment: Not reported
Research Site
Wakefield, England, United Kingdom
Site recruitment: Not reported
Research Site
Wiltshire, England, United Kingdom
Site recruitment: Not reported
Research Site
Aberdeen, Scotland, United Kingdom
Site recruitment: Not reported
Research Site
Dundee, Scotland, United Kingdom
Site recruitment: Not reported
Research Site
Carmathen, Wales, United Kingdom
Site recruitment: Not reported
Research Site
Swansea, Wales, United Kingdom
Site recruitment: Not reported
Research Site
Wrexham, Wales, United Kingdom
Site recruitment: Not reported
Research Site
Leytonstone, United Kingdom
Site recruitment: Not reported
Research Site
Livingston, United Kingdom
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 3CompletedINTERVENTIONAL

A Study Comparing Exenatide With Basal Insulin in Achieving a Target HbA1c With Minimum Weight Gain in Type 2 Diabetes Patients

ClinicalTrials.gov · NCT00360334 · Registry updated: 2015-04-07

Condition / research focus: Type 2 Diabetes
Sponsor: AstraZeneca
Countries with listed sites: United Kingdom
Registry dates and results: Start: 2006-06. Completion: 2008-04 (may be estimated). Results are posted in this registry.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

exenatide (drug) — also listed as: Byetta
insulin glargine (drug) — also listed as: Lantus

Where the study takes place — 31 listed sites

Research Site
Aberdeen, United Kingdom
Site recruitment: Not reported
Research Site
Bath, United Kingdom
Site recruitment: Not reported
Research Site
Blackburn, United Kingdom
Site recruitment: Not reported
Research Site
Bolton, United Kingdom
Site recruitment: Not reported
Research Site
Bournemouth, United Kingdom
Site recruitment: Not reported
Research Site
Bristol, United Kingdom
Site recruitment: Not reported
Research Site
Chippenham, United Kingdom
Site recruitment: Not reported
Research Site
Edinburgh, United Kingdom
Site recruitment: Not reported
Research Site
Glasgow, United Kingdom
Site recruitment: Not reported
Research Site
Haywards Heath, United Kingdom
Site recruitment: Not reported
Research Site
High Wycombe, United Kingdom
Site recruitment: Not reported
Research Site
Hull, United Kingdom
Site recruitment: Not reported
Research Site
Ipswich, United Kingdom
Site recruitment: Not reported
Research Site
Kent, United Kingdom
Site recruitment: Not reported
Research Site
Leicester, United Kingdom
Site recruitment: Not reported
Research Site
Liverpool, United Kingdom
Site recruitment: Not reported
Research Site
Livingstone, United Kingdom
Site recruitment: Not reported
Research Site
London, United Kingdom
Site recruitment: Not reported
Research Site
Manchester, United Kingdom
Site recruitment: Not reported
Research Site
Metropolitan Borough of Wirral, United Kingdom
Site recruitment: Not reported
Research Site
Middlesbrough, United Kingdom
Site recruitment: Not reported
Research Site
Norwich, United Kingdom
Site recruitment: Not reported
Research Site
Nottingham, United Kingdom
Site recruitment: Not reported
Research Site
Oldham, United Kingdom
Site recruitment: Not reported
Research Site
Oxford, United Kingdom
Site recruitment: Not reported
Research Site
Plymouth, United Kingdom
Site recruitment: Not reported
Research Site
Rochdale, United Kingdom
Site recruitment: Not reported
Research Site
Salford, United Kingdom
Site recruitment: Not reported
Research Site
Swansea, United Kingdom
Site recruitment: Not reported
Research Site
Torquay, United Kingdom
Site recruitment: Not reported
Research Site
Wakefield, United Kingdom
Site recruitment: Not reported

Original record, eligibility, contacts and results →